Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7207983, 42 pages
https://doi.org/10.1155/2017/7207983
Review Article

Phytotherapy and Nutritional Supplements on Breast Cancer

1Fernando Pessoa Energy, Environment, and Health Research Unit/Biomedical Research Center (FP-ENAS/CEBIMED), Faculty of Health Sciences, Fernando Pessoa University, Porto, Portugal
2EMAC (School of Alternative and Complementary Medicines), Porto, Portugal

Correspondence should be addressed to C. M. Lopes; tp.ude.pfu@sepolmc and R. Oliveira; tp.ude.pfu@oatir

Received 5 April 2017; Revised 14 June 2017; Accepted 18 June 2017; Published 6 August 2017

Academic Editor: Gail B. Mahady

Copyright © 2017 C. M. Lopes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Sowa, M. J. Downes, and L. G. Gordon, “RETRACTED ARTICLE: Cost-effectiveness of dual energy X-ray absorptiometry (DXA) plus anti-resorptive treatment in Australian women with breast cancer who receive aromatase inhibitors,” Journal of Bone and Mineral Metabolism, vol. 34, no. 2, p. 242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Soliman, S. Samadi, M. Banerjee, and Z. Aziz, “Brief Continuing Medical Education (CME) module raises knowledge of developing country physicians,” The International Electronic Journal of Health Education, vol. 9, pp. 31–41, 2006. View at Google Scholar
  3. R. E. Rossi, M. Pericleous, D. Mandair, T. Whyand, and M. E. Caplin, “The role of dietary factors in prevention and progression of breast cancer,” Anticancer Research, vol. 34, no. 12, pp. 6861–6875, 2014. View at Google Scholar
  4. WHO, World Health Organization: Breast Cancer: Prevention and Control, 2017, http://www.who.int/cancer/detection/breastcancer/en/index1.html.
  5. N. K. Lina, “Knowledge about breast cancer and negative influences affecting breast cancer screening among women in Jordan,” IJHSS, vol. 2, pp. 1–11, 2012. View at Google Scholar
  6. H. S. Boon, F. Olatunde, and S. M. Zick, “Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005,” BMC Women's Health, vol. 7, article 4, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Nagykálnai, L. Landherr, and A. C. Nagy, “Vitamin D and breast cancer,” Orvosi Hetilap, vol. 155, no. 28, pp. 1091–1096, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Alliance, The Regulatory Status of Complementary and Alternative Medicine for Medical Doctors in Europe, 2015, http://www.camdoc.eu/Pdf/CAMDOCRegulatoryStatus8_10.pdf.
  9. L. T. Nguyen, R. B. Davis, T. J. Kaptchuk, and R. S. Phillips, “Use of complementary and alternative medicine and self-rated health status: results from a national survey,” Journal of General Internal Medicine, vol. 26, no. 4, pp. 399–404, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Saquib, L. Madlensky, S. Kealey et al., “Classification of CAM use and its correlates in patients with early-stage breast cancer,” Integrative Cancer Therapies, vol. 10, no. 2, pp. 138–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Bennett, L. D. Cameron, L. C. Whitehead, and D. Porter, “Differences between older and younger cancer survivors in seeking cancer information and using complementary/alternative medicine,” Journal of General Internal Medicine, vol. 24, no. 10, pp. 1089–1094, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Wanchai, J. M. Armer, and B. R. Stewart, “Complementary and alternative medicine use among women with breast cancer: a systematic review,” Clinical Journal of Oncology Nursing, vol. 14, no. 4, pp. E45–E55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. National Center for Complementary and Integrative Medicine (NCCIM), Complementary, Alternative, or Integrative Health: What's in a Name?2015, https://nccih.nih.gov/health/integrative-health.
  14. National Cancer Institute (NCI), Thinking about Complementary and Alternative Medicine: A Guide for People with Cancer, 2015, http://www.cancer.gov/publications/patient-education/367NCINewV2.pdf.
  15. G. Dobos and I. Tao, “The model of Western integrative medicine: the role of Chinese medicine,” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 11–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. G. J. Dobos, P. Voiss, I. Schwidde et al., “Integrative oncology for breast cancer patients: Introduction of an expert-based model,” BMC Cancer, vol. 12, article no. 539, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Horneber, G. Bueschel, G. Dennert, D. Less, E. Ritter, and M. Zwahlen, “How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis,” Integrative Cancer Therapies, vol. 11, no. 3, pp. 187–203, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Micke, F. Bruns, M. Glatzel et al., “Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology,” European Journal of Integrative Medicine, vol. 1, no. 1, pp. 19–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Vidal, C. Carvalho, and R. Bispo, “Use of complementary and alternative medicine in a sample of women with breast cancer,” SAGE Open, pp. 1–4, 2013. View at Publisher · View at Google Scholar
  20. T. Gansler, C. Kaw, C. Crammer, and T. Smith, “A population-based study of prevalence of complementary methods use by cancer survivors: A report from the American cancer society's studies of cancer survivors,” Cancer, vol. 113, no. 5, pp. 1048–1057, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. V. S. Eschiti, “Lesson from comparison of CAM use by women with female-specific cancers to others: It's time to focus on interaction risks with CAM therapies,” Integrative Cancer Therapies, vol. 6, no. 4, pp. 313–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. Astin, C. Reilly, C. Perkins, and W. L. Child, “Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation,” Journal of the Society for Integrative Oncology, vol. 4, no. 4, pp. 157–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Tung, “What is the optimal endocrine therapy for postmenopausal women with hormone receptor-positive early breast cancer?” Journal of Clinical Oncology, vol. 31, no. 11, pp. 1391–1397, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Molassiotis, P. Fernandez-Ortega, D. Pud et al., “Use of complementary and alternative medicine in cancer patients: a European survey,” Annals of Oncology, vol. 16, no. 4, pp. 655–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Kremser, A. Evans, A. Moore et al., “Use of complementary therapies by Australian women with breast cancer,” The Breast, vol. 17, no. 4, pp. 387–394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Saquib, C. L. Rock, L. Natarajan et al., “Dietary intake, supplement use, and survival among women diagnosed with early-stage breast cancer,” Nutrition and Cancer, vol. 63, no. 3, pp. 327–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Hu, X. Yang, P. C. L. Ho et al., “Herb-drug interactions: a literature review,” Drugs, vol. 65, no. 9, pp. 1239–1282, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. G. A. Saxe, L. Madlensky, S. Kealey, D. P. H. Wu, K. L. Freeman, and J. P. Pierce, “Disclosure to physicians of CAM use by breast cancer patients: Findings from the women's healthy eating and living study,” Integrative Cancer Therapies, vol. 7, no. 3, pp. 122–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Cassidy, “Are herbal remedies and dietary supplements safe and effective for breast cancer patients?” Breast Cancer Research, vol. 5, no. 6, pp. 300–302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Ma, C. L. Carpenter, J. Sullivan-Halley, and L. Bernstein, “The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors - results of a prospective study,” BMC Cancer, vol. 11, article no. 222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. O. Omogbadegun, “Medicinal plants-based foods for breast cancer treatment: an ethnobotanical survey and digitization,” International Journal of Medicinal Plants and Alternative Medicine, vol. 1, pp. 137–163, 2013. View at Google Scholar
  32. M. J. Wargovich, C. Woods, D. M. Hollis, and M. E. Zander, “Herbals, cancer prevention and health,” Journal of Nutrition, vol. 131, no. 11, pp. 3034S–3036S, 2001. View at Google Scholar
  33. J. S. McLay, D. Stewart, J. George, C. Rore, and S. D. Heys, “Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?” European Journal of Clinical Pharmacology, vol. 68, no. 5, pp. 811–819, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Bright-Gbebry, K. H. Makambi, J. P. Rohan et al., “Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: The black women's health study,” BMC Complementary and Alternative Medicine, vol. 11, article no. 30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. W. J. Craig, “Health-promoting properties of common herbs,” Am J Clin Nutr, vol. 70, 3, pp. 491S–499S, 1999. View at Google Scholar
  36. S. N. Driggins, E. L. Myles, and T. Gary, “The anti-prolific effect of Echinacea Pallida on BT-549 cancer cell line,” Proc Amer Assoc Cancer Res, vol. 45, 2004. View at Google Scholar
  37. E. D. Huntimer, F. T. Halaweish, and C. C. L. Chase, “Proliferative activity of Echinacea angustifolia root extracts on cancer cells: Interference with doxorubicin cytotoxicity,” Chemistry and Biodiversity, vol. 3, no. 6, pp. 695–703, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Modarai, J. Gertsch, A. Suter, M. Heinrich, and A. Kortenkamp, “Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content,” Journal of Pharmacy and Pharmacology, vol. 59, no. 4, pp. 567–573, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. R. Penzak, S. M. Robertson, J. D. Hunt et al., “Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter Lopinavir-Ritonavir exposure in healthy subjects,” Pharmacotherapy, vol. 30, no. 8, pp. 797–805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. K. L. Goey, I. Meijerman, H. Rosing et al., “The effect of echinacea purpurea on the pharmacokinetics of docetaxel,” British Journal of Clinical Pharmacology, vol. 76, no. 3, pp. 467–474, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. CAM-CANCER, Echinacea spp, 2015, http://www.cam-cancer.org/CAM-Summaries/Herbal-products/Echinacea-spp/Does-it-work.
  42. J. T. Giles, C. T. Palat III, S. H. Chien, Z. G. Chang, and D. T. Kennedy, “Evaluation of echinacea for treatment of the common cold,” Pharmacotherapy, vol. 20, no. 6 I, pp. 690–697, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. S. E. Edwards, I. C. Rocha, E. M. Williamson, and M. Heinrich, Phytopharmacy: An Evidence-Based Guide to Herbal Medicinal Products, John Wiley & Sons, 2015.
  44. B. Mukherjee, N. Telang, and G. Y. C. Wong, “Growth inhibition of estrogen receptor positive human breast cancer cells by Taheebo from the inner bark of Tabebuia avellandae tree,” International Journal of Molecular Medicine, vol. 24, no. 2, pp. 253–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. J. Pink, S. Wuerzberger-Davis, C. Tagliarino et al., “Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone-mediated apoptosis,” Experimental Cell Research, vol. 255, no. 2, pp. 144–155, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. J. R. Gómez Castellanos, J. M. Prieto, and M. Heinrich, “Red Lapacho (Tabebuia impetiginosa)—a global ethnopharmacological commodity?” Journal of Ethnopharmacology, vol. 121, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. K. J. Ahn, H. S. Lee, S. K. Bai, and C. W. Song, “Enhancement of radiation effect using beta-lapachone and underlying mechanism,” Radiation Oncology Journal, vol. 31, no. 2, pp. 57–65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Tagliarino, J. J. Pink, G. R. Dubyak, A.-L. Nieminenll, and D. A. Boothman, “Calcium Is a Key Signaling Molecule in β-Lapachone-mediated Cell Death,” Journal of Biological Chemistry, vol. 276, no. 22, pp. 19150–19159, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. M.-T. Lin, C.-C. Chang, S.-T. Chen et al., “Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-κB-dependent XIAP up-regulation,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 24015–24023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. H. J. Park, K.-J. Ahn, S.-D. Ahn et al., “Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiation,” International Journal of Radiation Oncology, Biology, Physics, vol. 61, no. 1, pp. 212–219, 2005. View at Publisher · View at Google Scholar
  51. E. A. Bey, K. E. Reinicke, M. C. Srougi et al., “Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers,” Molecular Cancer Therapeutics, vol. 12, no. 10, pp. 2110–2120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Kung, K. S. Lu, and Y. P. Chau, “The chemotherapeutic effects of lapacho tree extract: β-lapachone,” Chemotherapy, vol. 3, no. 2, pp. 131–135, 2014. View at Google Scholar
  53. O. A. Lemos, J. C. M. Sanches, I. E. F. Silva et al., “Genotoxic effects of Tabebuia impetiginosa (Mart. Ex DC.) Standl. (Lamiales, Bignoniaceae) extract in Wistar rats,” Genetics and Molecular Biology, vol. 35, no. 2, pp. 498–502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. C. K. Wong, Y. X. Bao, E. L. Wong, P. C. Leung, K. P. Fung, and C. W. Lam, “Immunomodulatory activities of Yunzhi and Danshen in post-treatment breastcancer patients,” The American Journal of Chinese Medicine, vol. 33, no. 3, pp. 381–395, 2005. View at Publisher · View at Google Scholar
  55. J. Chen, Q. Lv, M. Yu, X. Zhang, and J. Gou, “Randomized clinical trial of Chinese herbal medications to reduce wound complications after mastectomy for breast carcinoma,” British Journal of Surgery, vol. 97, no. 12, pp. 1798–1804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Santos Araujo Mdo, I. L. Farias, J. Gutierres et al., “Uncaria tomentosa—adjuvant treatment for breast cancer: clinical trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 676984, 8 pages, 2012. View at Publisher · View at Google Scholar
  57. A. Pourzand, A. Tajaddini, S. Pirouzpanah et al., “Associations between dietary alliumvegetables and risk of breast cancer: A hospital-based matched case-control study,” Journal of Breast Cancer, vol. 19, no. 3, pp. 292–300, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. M. C. Cox, J. Low, J. Lee et al., “Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel,” Clinical Cancer Research, vol. 12, no. 15, pp. 4636–4640, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. E. C. Lowcock, M. Cotterchio, and B. A. Boucher, “Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk,” Cancer Causes and Control, vol. 24, no. 4, pp. 813–816, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Lindahl, N. Saarinen, A. Abrahamsson, and C. Dabrosin, “Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer,” Cancer Research, vol. 71, no. 1, pp. 51–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. U. W. Nilsson Åberg, N. Saarinen, A. Abrahamsson, T. Nurmi, S. Engblom, and C. Dabrosin, “Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo,” PLoS ONE, vol. 6, no. 9, Article ID e25720, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. S. E. McCann, S. B. Edge, D. G. Hicks et al., “A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers,” Nutrition and Cancer, vol. 66, no. 4, pp. 566–575, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Buck, A. K. Zaineddin, A. Vrieling et al., “Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer,” British Journal of Cancer, vol. 105, no. 8, pp. 1151–1157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Bayet-Robert, F. Kwiatowski, M. Leheurteur et al., “Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer,” Cancer Biology & Therapy, vol. 9, no. 1, pp. 8–14, 2010. View at Publisher · View at Google Scholar
  65. Y.-F. Zhang, Q. Xu, J. Lu et al., “Tea consumption and the incidence of cancer: A systematic review and meta-analysis of prospective observational studies,” European Journal of Cancer Prevention, vol. 24, no. 4, pp. 353–362, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Iwasaki, M. Inoue, S. Sasazuki et al., “Green tea drinking and subsequent risk of breast cancer in a population to based cohort of Japanese women,” Breast Cancer Research, vol. 12, no. 5, article no. R88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Zhang, C. D. J. Holman, J.-P. Huang, and X. Xie, “Green tea and the prevention of breast cancer: A case-control study in Southeast China,” Carcinogenesis, vol. 28, no. 5, pp. 1074–1078, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Iwasaki, M. Inoue, S. Sasazuki et al., “Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: A nested case-control study,” Breast Cancer Research and Treatment, vol. 124, no. 3, pp. 827–834, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Luo, Y.-T. Gao, W.-H. Chow et al., “Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study,” Breast Cancer Research and Treatment, vol. 120, no. 3, pp. 693–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. K. D. Crew, K. A. Ho, P. Brown et al., “Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer,” Journal of Human Nutrition and Dietetics, vol. 28, no. 3, pp. 272–282, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. J.-M. Yuan, W.-P. Koh, C.-L. Sun, H.-P. Lee, and M. C. Yu, “Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore,” Carcinogenesis, vol. 26, no. 8, pp. 1389–1394, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Inoue-Choi, J. M. Yuan, Yang C. S. et al., “Genetic association between the COMT genotype and urinary levels of tea polyphenols and their metabolites among daily green tea drinkers,” International Journal of Molecular Epidemiology and Genetics, vol. 1, no. 2, pp. 114–123, 2010. View at Google Scholar
  73. A. H. Wu, Tseng C. C., D. Van Den Berg, and M. C. Yu, “Tea intake, COMT genotype, and breast cancer in Asian-American women,” Cancer Research, vol. 63, no. 21, pp. 7526–7529, 2003. View at Google Scholar
  74. G. Zhang, Y. Wang, Y. Zhang et al., “Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy,” Current Molecular Medicine, vol. 12, no. 2, pp. 163–176, 2012. View at Google Scholar
  75. A. M. Dostal, H. Samavat, S. Bedell et al., “The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial,” Food and Chemical Toxicology, vol. 83, pp. 26–35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Lazzeroni, A. Guerrieri-Gonzaga, S. Gandini et al., “A presurgical study of lecithin formulation of green tea extract in women with early breast cancer,” Cancer Prevention Research (Phila), vol. 10, no. 6, pp. 363–370, 2017. View at Publisher · View at Google Scholar
  77. D. Seely, E. J. Mills, P. Wu, S. Verma, and G. H. Guyatt, “The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: A systematic review and meta-analysis,” Integrative Cancer Therapies, vol. 4, no. 2, pp. 144–155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. J. W. Liu, S. Liangxin, Z. Yi et al., “Clinical phase II study on immunoimprovement of patients with breast cancer treated by Shengyi capsule,” Chinese Journal of Clinical Oncology, vol. 27, pp. 534–544, 2000. View at Google Scholar
  79. P.-P. Bao, W. Lu, Y. Cui et al., “Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai breast cancer survival study,” PLoS ONE, vol. 7, no. 6, Article ID e39343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. Cui, X.-O. Shu, Y.-T. Gao, H. Cai, M.-H. Tao, and W. Zheng, “Association of ginseng use with survival and quality of life among breast cancer patients,” American Journal of Epidemiology, vol. 163, no. 7, pp. 645–653, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. H. Fritz, D. Seely, J. McGowan et al., “Black cohosh and breast cancer: A systematic review,” Integrative Cancer Therapies, vol. 13, no. 1, pp. 12–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. H. H. Henneicke-von Zepelin, H. Meden, K. Kostev, D. Schröder-Bernhardi, U. Stammwitz, and H. Becher, “Isopropanolic black cohosh extract and recurrence-free survival after breast cancer,” Int. Journal of Clinical Pharmacology and Therapeutics, vol. 45, no. 3, pp. 143–154, 2007. View at Publisher · View at Google Scholar
  83. S. Roy, “Breast Tumour Regression using Mistletoe Extract: An evidence from an Indian Clinic,” Helix, vol. 1, pp. 651–655, 2015. View at Google Scholar
  84. W. Tröger, Z. Zdrale, N. Tišma, and M. Matijašević, “Additional therapy with a mistletoe product during adjuvant chemotherapy of breast cancer patients improves quality of life: an open randomized clinical pilot trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 430518, 9 pages, 2014. View at Publisher · View at Google Scholar
  85. W. Tröger, Z. Ždrale, N. Stanković, and M. Matijašević, “Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with Viscum album (L.) extract to chemotherapy alone,” Breast Cancer: Basic and Clinical Research, vol. 6, no. 1, pp. 173–180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Eisenbraun, R. Scheer, M. Kröz, F. Schad, and R. Huber, “Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract,” Phytomedicine, vol. 18, no. 2-3, pp. 151–157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Büssing, U. Brückner, and U. Enser-Weis, “Modulation of chemotherapy-associated immunosuppression by intravenous application of Viscum album L. extract (Iscador): a randomised phase II study,” European Journal of Integrative Medicine, vol. 1, pp. 2-3, 2008. View at Publisher · View at Google Scholar
  88. J. Beuth, B. Schneider, and J. M. Schierholz, “mpact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study,” Anticancer Research, vol. 28, no. 1B, pp. 523–527, 2008. View at Google Scholar · View at Scopus
  89. A. C. Gören, T. Kiliç, T. Dirmenci, and G. Bilsel, “Chemotaxonomic evaluation of Turkish species of Salvia: Fatty acid compositions of seed oils,” Biochemical Systematics and Ecology, vol. 34, no. 2, pp. 160–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Abu-Dahab, F. Afifi, V. Kasabri, L. Majdalawi, and R. Naffa, “Comparison of the antiproliferative activity of crude ethanol extracts of nine salvia species grown in Jordan against breast cancer cell line models,” Pharmacognosy Magazine, vol. 8, no. 32, pp. 319–324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. R. Abu-Dahab, M. R. Abdallah, V. Kasabri, N. M. Mhaidat, and F. U. Afifi, “Mechanistic studies of antiproliferative effects of salvia triloba and salvia dominica (Lamiaceae) on breast cancer cell lines (MCF7 and T47D),” Zeitschrift für Naturforschung, vol. 69c, pp. 443–451, 2015. View at Google Scholar
  92. W. Yang, J.-H. Ju, M. J. Jeon, X. Han, and I. Shin, “Danshen (Salvia miltiorrhiza) extract inhibits proliferation of breast cancer cells via modulation of akt activity and p27 level,” Phytotherapy Research, vol. 24, no. 2, pp. 198–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Baselga, E. A. Perez, T. Pienkowski, and R. Bell, “Adjuvant trastuzumab: A milestone in the treatment of HER-2-positive early breast cancer,” Oncologist, vol. 11, no. 1, pp. 4–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Dowsett, “Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer,” Endocrine-Related Cancer, vol. 8, no. 3, pp. 191–195, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. X. Wang, Y. Wei, S. Yuan et al., “Potential anticancer activity of tanshinone IIA against human breast cancer,” International Journal of Cancer, vol. 116, no. 5, pp. 799–807, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. X. Wang, K. F. Bastow, C.-M. Sun et al., “Antitumor agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza,” Journal of Medicinal Chemistry, vol. 47, no. 23, pp. 5816–5819, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. I. T. Nizamutdinova, G. W. Lee, K. H. Son et al., “Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells,” International Journal of Oncology, vol. 33, no. 3, pp. 485–491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. Y. Gong, Y. Li, H. M. Abdolmaleky, L. Li, and J.-R. Zhou, “Tanshinones inhibit the growth of breast cancer cells through epigenetic modification of aurora a expression and function,” PLoS ONE, vol. 7, no. 4, Article ID e33656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. V. Nicolin, G. Fancellu, and R. Valentini, “Effect of tanshinone II on cell growth of breast cancer cell line type MCF-7 and MD-MB-231,” Italian Journal of Anatomy and Embryology, vol. 119, no. 1, pp. 38–43, 2014. View at Google Scholar
  100. J. Cai, S. Chen, W. Zhang et al., “Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway,” Phytomedicine, vol. 21, no. 12, pp. 1725–1732, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. P. Fu, F. Du, W. Chen, M. Yao, K. Lv, and Y. Liu, “Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines,” Oncology Reports, vol. 31, no. 6, pp. 2561–2568, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. L. Riva, D. Coradini, G. Di Fronzo et al., “The antiproliferative effects of Uncaria tomentosa extracts and fractions on the growth of breast cancer cell line,” Anticancer Research, vol. 21, no. 4A, pp. 2457–2461, 2001. View at Google Scholar
  103. CAM-CANCER, Cat's Claw (Uncaria spp), 2015, http://www.cam-cancer.org/CAM-Summaries/Herbal-products/Cat-s-claw-Uncaria-spp/What-is-it.
  104. S. Y. Pan, J. Zhou, L. Gibbons, H. Morrison, and S. W. Wen, “Antioxidants and breast cancer risk- a population-based case-control study in Canada,” BMC Cancer, vol. 11, article no. 372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. S. C. Larsson, A. Åkesson, L. Bergkvist, and A. Wolk, “Multivitamin use and breast cancer incidence in a prospective cohort of Swedish women,” American Journal of Clinical Nutrition, vol. 91, no. 5, pp. 1268–1272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. J. M. Meulepas, P. A. Newcomb, A. N. Burnett-Hartman, J. M. Hampton, and A. Trentham-Dietz, “Multivitamin supplement use and risk of invasive breast cancer,” Public Health Nutrition, vol. 13, no. 10, pp. 1540–1545, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. P. G. Moorman, M. F. Ricciuti, R. C. Millikan, and B. Newman, “Vitamin supplement use and breast cancer in a North Carolina population,” Public Health Nutrition, vol. 4, no. 3, pp. 821–827, 2001. View at Publisher · View at Google Scholar · View at Scopus
  108. C. Wang, R. N. Baumgartner, D. Yang et al., “No evidence of association between breast cancer risk and dietary carotenoids, retinols, vitamin C and tocopherols in Southwestern Hispanic and non-hispanic white women,” Breast Cancer Research and Treatment, vol. 114, no. 1, pp. 137–145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. G. Nagel, J. Linseisen, C. H. van Gils et al., “Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European prospective investigation into cancer and nutrition (EPIC),” Breast Cancer Research and Treatment, vol. 119, pp. 753–765, 2010. View at Google Scholar
  110. A. Pantavos, R. Ruiter, E. F. Feskens et al., “Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: The Rotterdam study,” International Journal of Cancer, vol. 136, no. 9, pp. 2178–2186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Wassertheil-Smoller, A. P. McGinn, N. Budrys et al., “Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women's health initiative,” Breast Cancer Research and Treatment, vol. 141, no. 3, pp. 495–505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. E. M. Poole, X. Shu, B. J. Caan et al., “Postdiagnosis supplement use and breast cancer prognosis in the after Breast Cancer Pooling Project,” Breast Cancer Research and Treatment, vol. 139, no. 2, pp. 529–537, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. M. L. Kwan, H. Greenlee, V. S. Lee et al., “Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: The life after cancer epidemiology study,” Breast Cancer Research and Treatment, vol. 130, no. 1, pp. 195–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. M. L. Lesperance, I. A. Olivotto, N. Forde et al., “Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study,” Breast Cancer Research and Treatment, vol. 76, no. 2, pp. 137–143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Hu, Z. Wu, G. Li et al., “The plasma level of retinol, vitamins A, C and α-tocopherol could reduce breast cancer risk? A meta-analysis and meta-regression,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 4, pp. 601–614, 2015. View at Publisher · View at Google Scholar · View at Scopus
  116. C. Pouchieu, P. Galan, V. Ducros, P. Latino-Martel, S. Hercberg, and M. Touvier, “Plasma carotenoids and retinol and overall and breast cancer risk: a nested case-control study,” Nutrition and cancer, vol. 66, no. 6, pp. 980–988, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. L. I. Mignone, E. Giovannucci, P. A. Newcomb et al., “Dietary carotenoids and the risk of invasive breast cancer,” International Journal of Cancer, vol. 124, no. 12, pp. 2929–2937, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. J. P. Huang, M. Jain, A. B. Miller, G. R. Howe, and T. E. Rohan, “Dietary carotenoids and risk of breast cancer in Chinese women,” Asia Pacific Journal of Clinical Nutrition, vol. 16, pp. 437–442, 2007. View at Google Scholar
  119. G. C. Kabat, M. Kim, L. L. Adams-Campbell et al., “Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women,” American Journal of Clinical Nutrition, vol. 90, no. 1, pp. 162–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. Y. Cui, J. M. Shikany, S. Liu, Y. Shagufta, and T. E. Rohan, “Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the women's health initiative observational study,” The American Journal of Clinical Nutrition, vol. 87, no. 4, pp. 1009–1018, 2008. View at Google Scholar
  121. M. F. Bakker, P. H. Peeters, V. M. Klaasen et al., “Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European prospective investigation into cancer and nutrition cohort,” The American Journal of Clinical Nutrition, vol. 103, no. 2, pp. 454–464, 2016. View at Google Scholar
  122. C. L. Rock, L. Natarajan, M. Pu et al., “Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the women's healthy eating and living study,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 2, pp. 486–494, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Hutchinson, V. J. Burley, D. C. Greenwood, J. D. Thomas, and J. E. Cade, “High-dose vitamin C supplement use is associated with self-reported histories of breast cancer and other illnesses in the UK Women's Cohort Study,” Public Health Nutrition, vol. 14, no. 5, pp. 768–777, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. C. Cadeau, A. Fournier, S. Mesrine, F. Clavel-Chapelon, G. Fagherazzi, and M.-C. Boutron-Ruault, “Vitamin C supplement intake and postmenopausal breast cancer risk: Interaction with dietary vitamin C,” American Journal of Clinical Nutrition, vol. 104, no. 1, pp. 228–234, 2016. View at Publisher · View at Google Scholar · View at Scopus
  125. H. R. Harris, L. Bergkvist, and A. Wolk, “Vitamin C intake and breast cancer mortality in a cohort of Swedish women,” British Journal of Cancer, vol. 109, no. 1, pp. 257–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. H. R. Harris, N. Orsini, and A. Wolk, “Vitamin C and survival among women with breast cancer: A Meta-analysis,” European Journal of Cancer, vol. 50, no. 7, pp. 1223–1231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  127. J. Ramesh Babu, S. Sundravel, G. Arumugam, R. Renuka, N. Deepa, and P. Sachdanandam, “Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels,” Cancer Letters, vol. 151, no. 1, pp. 1–5, 2000. View at Publisher · View at Google Scholar · View at Scopus
  128. N. Suhail, N. Bilal, H. Y. Khan et al., “Effect of vitamins C and e on antioxidant status of breast-cancer patients undergoing chemotherapy,” Journal of Clinical Pharmacy and Therapeutics, vol. 37, no. 1, pp. 22–26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  129. A. C. Carr, M. C. Vissers, and J. Cook, “Relief from cancer chemotherapy side effects with pharmacologic vitamin C,” New Zealand Medical Journal, vol. 127, no. 1388, pp. 66–70, 2014. View at Google Scholar · View at Scopus
  130. C. Vollbracht, B. Schneider, V. Leendert, G. Weiss, L. Auerbach, and J. Beuth, “Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany,” In Vivo, vol. 25, no. 6, pp. 983–990, 2011. View at Google Scholar · View at Scopus
  131. M. Saintot, H. Mathieu-Daude, C. Astre, J. Grenier, J. Simony-Lafontaine, and M. Gerber, “Oxidant-antioxidant status in relation to survival among breast cancer patients,” International Journal of Cancer, vol. 97, no. 5, pp. 574–579, 2002. View at Publisher · View at Google Scholar · View at Scopus
  132. E. A. Peralta, A. T. Brewer, S. Louis, and G. L. Dunnington, “Vitamin E Increases Biomarkers of Estrogen Stimulation When Taken With Tamoxifen,” Journal of Surgical Research, vol. 153, no. 1, pp. 143–147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Magnusson, P. Höglund, K. Johansson et al., “Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5),” European Journal of Cancer, vol. 45, no. 14, pp. 2488–2495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. S. Delanian, R. Porcher, S. Balla-Mekias, and J.-L. Lefaix, “Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis,” Journal of Clinical Oncology, vol. 21, no. 13, pp. 2545–2550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  135. L. Teleni, J. Baker, B. Koczwara et al., “Clinical outcomes of vitamin D deficiency and supplementation in cancer patients,” Nutrition Reviews, vol. 71, no. 9, pp. 611–621, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. F. Sperati, P. Vici, M. Maugeri-Saccà et al., “Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials,” PLoS ONE, vol. 8, no. 7, Article ID e69269, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. S. B. Mohr, E. D. Gorham, J. E. Alcaraz et al., “Serum 25-hydroxyvitamin D and breast cancer in the military: A case-control study utilizing pre-diagnostic serum,” Cancer Causes and Control, vol. 24, no. 3, pp. 495–504, 2013. View at Publisher · View at Google Scholar · View at Scopus
  138. K. Edvardsen, M. B. Veierød, M. Brustad, T. Braaten, O. Engelsen, and E. Lund, “Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk,” International Journal of Cancer, vol. 128, no. 6, pp. 1425–1433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. S. C. Larsson, L. Bergkvist, and A. Wolk, “Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women,” American Journal of Clinical Nutrition, vol. 89, no. 1, pp. 277–282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  140. S. M. Boyapati, X. O. Shu, F. Jin et al., “Dietary calcium intake and breast cancer risk among Chinese women in Shanghai,” Nutrition and Cancer, vol. 46, no. 1, pp. 38–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  141. S. Abbas, J. Linseisen, S. Rohrmann et al., “Dietary Intake of Vitamin D and Calcium and Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition,” Nutrition and Cancer, vol. 65, no. 2, pp. 178–187, 2013. View at Google Scholar
  142. L. N. Anderson, M. Cotterchio, R. Vieth, and J. A. Knight, “Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women,” American Journal of Clinical Nutrition, vol. 91, no. 6, pp. 1699–1707, 2010. View at Publisher · View at Google Scholar · View at Scopus
  143. T. E. Rohan, A. Negassa, R. T. Chlebowski et al., “A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease,” Breast Cancer Research and Treatment, vol. 116, no. 2, pp. 339–350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  144. R. T. Chlebowski, Johnson K. C., C. Kooperberg et al., “Calcium plus Vitamin D supplementation and the risk of breast cancer,” Journal of the National Cancer Institute, vol. 100, no. 22, pp. 1581–1591, 2008. View at Publisher · View at Google Scholar
  145. S. Scarmo, Y. Afanasyeva, P. Lenner et al., “Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: A nested case-control study,” Breast Cancer Research, vol. 15, no. 1, article no. R15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  146. A. H. Eliassen, D. Spiegelman, B. W. Hollis, R. L. Horst, W. C. Willett, and S. E. Hankinson, “Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II,” Breast Cancer Research, vol. 13, no. 3, article no. R50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  147. B. L. Sprague, H. G. Skinner, A. Trentham-Dietz, K. E. Lee, B. E. K. Klein, and R. Klein, “Serum Calcium and Breast Cancer Risk in a Prospective Cohort Study,” Annals of Epidemiology, vol. 20, no. 1, pp. 82–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. J. Li, W.-P. Koh, A.-Z. Jin, J.-M. Yuan, M. C. Yu, and L. M. Butler, “Calcium intake is not related to breast cancer risk among Singapore Chinese women,” International Journal of Cancer, vol. 133, no. 3, pp. 680–686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  149. C.-X. Zhang, S. C. Ho, J.-H. Fu, S.-Z. Cheng, Y.-M. Chen, and F.-Y. Lin, “Dairy products, calcium intake, and breast cancer risk: A case-control study in China,” Nutrition and Cancer, vol. 63, no. 1, pp. 12–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  150. P. Engel, G. Fagherazzi, A. Boutten et al., “Serum 25(OH) vitamin D and risk of breast cancer: A nested case-control study from the French E3N cohort,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 9, pp. 2341–2350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  151. E. Kesse-Guyot, S. Bertrais, B. Duperray et al., “Dairy products, calcium and the risk of breast cancer: Results of the French SU.VI.MAX prospective study,” Annals of Nutrition and Metabolism, vol. 51, no. 2, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  152. P. Engel, G. Fagherazzi, S. Mesrine, M.-C. Boutron-Ruault, and F. Clavel-Chapelon, “Joint effects of dietary vitamin d and sun exposure on breast cancer risk: Results from the French E3N cohort,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 1, pp. 187–195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  153. M. Rossi, J. K. McLaughlin, P. Lagiou et al., “Vitamin D intake and breast cancer risk: a case-control study in Italy,” Annals of Oncology, vol. 20, no. 2, pp. 374–378, 2009. View at Publisher · View at Google Scholar
  154. U. Shamsi, S. Khan, S. Usman, S. Soomro, and I. Azam, “A multicenter matched case control study of breast cancer risk factors among women in Karachi, Pakistan,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 1, pp. 183–188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  155. M.-S. Lee, Y.-C. Huang, M. L. Wahlqvist et al., “Vitamin d decreases risk of breast cancer in premenopausal women of normal weight in subtropical Taiwan,” Journal of Epidemiology, vol. 21, no. 2, pp. 87–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. K. Bilinski and J. Boyages, “Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study,” Breast Cancer Research and Treatment, vol. 137, no. 2, pp. 599–607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  157. P. Chen, P. Hu, D. Xie, Y. Qin, F. Wang, and H. Wang, “Meta-analysis of vitamin D, calcium and the prevention of breast cancer,” Breast Cancer Research and Treatment, vol. 121, no. 2, pp. 469–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. T. Kawase, K. Matsuo, T. Suzuki et al., “Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan,” Cancer Science, vol. 101, no. 5, pp. 1234–1240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  159. M. Deschasaux, J.-C. Souberbielle, P. Latino-Martel et al., “Weight status and alcohol intake modify the association between vitamin D and breast cancer risk,” Journal of Nutrition, vol. 146, no. 3, pp. 576–585, 2016. View at Publisher · View at Google Scholar · View at Scopus
  160. A. H. Eliassen, E. T. Warner, B. Rosner et al., “Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years,” Cancer Research, vol. 76, no. 18, pp. 5423–5430, 2016. View at Publisher · View at Google Scholar · View at Scopus
  161. Y. Jamshidinaeini, M. E. Akbari, M. Abdollahi, M. Ajami, and S. H. Davoodi, “Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case–Control Study,” Journal of the American College of Nutrition, vol. 35, no. 7, pp. 639–646, 2016. View at Publisher · View at Google Scholar · View at Scopus
  162. S. Park, D. H. Lee, J. Y. Jeon et al., “Serum 25-hydroxyvitamin D deficiency and increased risk of breast cancer among Korean women: a case–control study,” Breast Cancer Research and Treatment, vol. 152, no. 1, pp. 147–154, 2015. View at Publisher · View at Google Scholar · View at Scopus
  163. Y. Kim, A. A. Franke, Y. B. Shvetsov et al., “Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: A nested case-control study in the multiethnic cohort study,” BMC Cancer, vol. 14, no. 1, article no. 29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  164. K. D. Crew, M. D. Gammon, S. E. Steck et al., “Association between plasma 25-hydroxyvitamin D and breast cancer risk,” Cancer Prevention Research, vol. 2, no. 6, pp. 598–604, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. T. Kuhn, R. Kaaks, S. Becker et al., “Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study,” International Journal of Cancer, vol. 133, no. 7, pp. 1689–1700, 2013. View at Google Scholar
  166. S. Abbas, J. Chang-Claude, and J. Linseisen, “Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study,” International Journal of Cancer, vol. 124, no. 1, pp. 250–255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  167. C. M. N. Oliveira-Sediyama, M. M. Dos Santos Dias, M. C. Pessoa et al., “Lifestyle and vitamin D dosage in women with breast cancer,” Nutricion Hospitalaria, vol. 33, no. 5, pp. 1179–1186, 2016. View at Publisher · View at Google Scholar · View at Scopus
  168. S. R. Bauer, S. E. Hankinson, E. R. Bertone-Johnson, and E. L. Ding, “Plasma vitamin d levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies,” Medicine, vol. 92, no. 3, pp. 123–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  169. M. Almquist, J. Manjer, L. Bondeson, and A.-G. Bondeson, “Serum calcium and breast cancer risk: Results from a prospective cohort study of 7,847 women,” Cancer Causes and Control, vol. 18, no. 6, pp. 595–602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  170. D. Wang, O. I. Vélez De-La-Paz, J.-X. Zhai, and D.-W. Liu, “Serum 25-hydroxyvitamin D and breast cancer risk: A meta-analysis of prospective studies,” Tumor Biology, vol. 34, no. 6, pp. 3509–3517, 2013. View at Publisher · View at Google Scholar · View at Scopus
  171. W. Wulaningsih, H. K. Sagoo, M. Hamza et al., “Serum calcium and the risk of breast cancer: Findings from the Swedish AMORIS study and a meta-analysis of prospective studies,” International Journal of Molecular Sciences, vol. 17, no. 9, article no. 1487, 2016. View at Publisher · View at Google Scholar · View at Scopus
  172. L. Huss, S. Butt, S. Borgquist, M. Almquist, J. Malm, and J. Manjer, “Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer,” Cancer Causes and Control, vol. 25, no. 9, pp. 1131–1140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  173. L. Shirazi, M. Almquist, S. Borgquist, J. Malm, and J. Manjer, “Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: A nested case-control study,” Breast, vol. 28, pp. 184–190, 2016. View at Publisher · View at Google Scholar · View at Scopus
  174. J. D. McKay, M. L. McCullough, R. G. Ziegler et al., “Vitamin D receptor polymorphisms and breast cancer risk: results from the national cancer institute breast and prostate cancer cohort consortium,” Cancer Epidemiology, Biomarkers & Prevention, vol. 18, no. 1, pp. 197–305, 2009. View at Google Scholar
  175. J. Shi, A. Grundy, H. Richardson et al., “Genetic variation in vitamin D-related genes and risk of breast cancer among women of European and East Asian descent,” Tumor Biology, vol. 37, no. 5, pp. 6379–6387, 2016. View at Publisher · View at Google Scholar · View at Scopus
  176. D. E. Rollison, A. L. Cole, K.-H. Tung et al., “Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.,” Breast Cancer Research and Treatment, vol. 132, no. 2, pp. 683–691, 2012. View at Publisher · View at Google Scholar · View at Scopus
  177. H. J. Kim, Y. M. Lee, B. S. Ko et al., “Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer,” Annals of Surgical Oncology, vol. 18, no. 7, pp. 1830–1836, 2011. View at Publisher · View at Google Scholar · View at Scopus
  178. B. Trabert, K. E. Malone, J. R. Daling et al., “Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women,” Breast Cancer Research, vol. 9, no. 6, p. R84, 2007. View at Publisher · View at Google Scholar
  179. E. T. Jacobs, C. A. Thomson, S. W. Flatt et al., “Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study,” American Journal of Clinical Nutrition, vol. 93, no. 1, pp. 108–117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  180. M. A. Tao, Q. Dai, A. E. Millen et al., “Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from western New York exposures and breast cancer (WEB) study,” Cancer Research, vol. 6, no. 1, pp. 105–113, 2015. View at Publisher · View at Google Scholar
  181. P. J. Goodwin, M. Ennis, K. I. Pritchard, J. Koo, and N. Hood, “Prognostic effects of 25-hydroxy vitamin D levels in early breast cancer,” Journal of Clinical Oncology, vol. 27, no. 23, pp. 3757–3763, 2009. View at Publisher · View at Google Scholar
  182. A. Villaseñor, R. Ballard-Barbash, A. Ambs et al., “Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors,” Cancer Causes and Control, vol. 24, no. 4, pp. 759–767, 2013. View at Publisher · View at Google Scholar · View at Scopus
  183. L. J. Peppone, A. S. Rickles, M. C. Janelsins, M. R. Insalaco, and K. A. Skinner, “The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels,” Annals of Surgical Oncology, vol. 19, no. 8, pp. 2590–2599, 2012. View at Publisher · View at Google Scholar · View at Scopus
  184. S. Yao, L. E. Sucheston, A. E. Millen et al., “Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: A case-control and a case-series study,” PLoS ONE, vol. 6, no. 2, Article ID e17251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  185. M. Almquist, L. Anagnostaki, L. Bondeson et al., “Serum calcium and tumour aggressiveness in breast cancer: A prospective study of 7847 women,” European Journal of Cancer Prevention, vol. 18, no. 5, pp. 354–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  186. K. D. Crew, E. Shane, S. Cremers, D. J. McMahon, D. Irani, and D. L. Hershman, “High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy,” Journal of Clinical Oncology, vol. 27, no. 13, pp. 2151–2156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  187. A. C. Shapiro, S. A. Adlis, K. Robien et al., “Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS),” Breast Cancer Research and Treatment, vol. 155, no. 3, pp. 501–512, 2016. View at Publisher · View at Google Scholar
  188. E. Amir, C. E. Simmons, O. C. Freedman et al., “A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases,” Cancer, vol. 116, no. 2, pp. 284–291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  189. M. Datta and G. G. Schwartz, “Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy,” Critical Reviews in Oncology/Hematology, vol. 88, no. 3, pp. 613–624, 2013. View at Publisher · View at Google Scholar · View at Scopus
  190. Q. J. Khan, P. S. Reddy, B. F. Kimler et al., “Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer,” Breast Cancer Research and Treatment, vol. 119, no. 1, pp. 111–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  191. A. L. Rastelli, M. E. Taylor, F. Gao et al., “Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial,” Breast Cancer Research and Treatment, vol. 129, no. 1, pp. 107–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  192. S. Arul Vijaya Vani, P. H. Ananthanarayanan, D. Kadambari, K. T. Harichandrakumar, R. Niranjjan, and H. Nandeesha, “Effects of vitamin D and calcium supplementation on side effects profile in patients of breast cancer treated with letrozole,” Clinica Chimica Acta, vol. 459, pp. 53–56, 2016. View at Publisher · View at Google Scholar · View at Scopus
  193. D. Prieto-Alhambra, M. K. Javaid, S. Servitja et al., “Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: A prospective cohort study,” Breast Cancer Research and Treatment, vol. 125, no. 3, pp. 869–878, 2011. View at Publisher · View at Google Scholar · View at Scopus
  194. D. Prieto-Alhambra, S. Servitja, M. K. Javaid et al., “Vitamin D threshold to prevent aromatase inhibitor-related bone loss: The B-ABLE prospective cohort study,” Breast Cancer Research and Treatment, vol. 133, no. 3, pp. 1159–1167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  195. S. J. Kim, A. Zuchniak, K.-J. Sohn et al., “Plasma folate, Vitamin B-6, and Vitamin B-12 and breast cancer risk in BRCA1- And BRCA2-mutation carriers: A prospective study,” American Journal of Clinical Nutrition, vol. 104, no. 3, pp. 671–677, 2016. View at Publisher · View at Google Scholar · View at Scopus
  196. S. M. Zhang, N. R. Cook, C. M. Albert, J. M. Gaziano, J. E. Buring, and J. E. Manson, “Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women. a randomized trial,” The Journal of the American Medical Association, vol. 300, pp. 2012–2021, 2008. View at Publisher · View at Google Scholar
  197. M. Liu, L.-H. Cui, A.-G. Ma, N. Li, and J.-M. Piao, “Lack of effects of dietary folate intake on risk of breast cancer: An updated meta-analysis of prospective studies,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 5, pp. 2323–2328, 2014. View at Publisher · View at Google Scholar · View at Scopus
  198. M. Tio, J. Andrici, and G. D. Eslick, “Folate intake and the risk of breast cancer: A systematic review and meta-analysis,” Breast Cancer Research and Treatment, vol. 145, no. 2, pp. 513–524, 2014. View at Publisher · View at Google Scholar · View at Scopus
  199. J. K. Bassett, L. Baglietto, A. M. Hodge et al., “Dietary intake of B vitamins and methionine and breast cancer risk,” Cancer Causes and Control, vol. 24, no. 8, pp. 1555–1563, 2013. View at Publisher · View at Google Scholar · View at Scopus
  200. T. A. Sellers, S. R. Alberts, R. A. Vierkant et al., “High-folate diets and breast cancer survival in a prospective cohort study,” Nutrition and Cancer, vol. 44, no. 2, pp. 139–144, 2002. View at Publisher · View at Google Scholar · View at Scopus
  201. C. Castillo-L, J. A. Tur, and R. Uauy, “Folate and breast cancer risk. A systematic review,” Revista Medica de Chile, vol. 140, no. 2, pp. 251–260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  202. J. Lin, I. M. Lee, Cook N. R. et al., “Plasma folate, vitamin B-6, vitamin B-12 and risk of breast cancer in women,” The American Journal of Clinical Nutrition, vol. 87, pp. 734–743, 2008. View at Google Scholar
  203. E. Riboli, K. J. Hunt, N. Slimani et al., “European prospective investigation into cancer and nutrition (EPIC): study populations and data collection,” Public Health Nutrition, vol. 5, no. 6, pp. 1113–1124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  204. G. Rukundo, M. Galukande, P. Ongom, and J. O. Fualal, “Red blood cell folate as a risk factor for breast cancer among patients at a tertiary hospital in Uganda: A case control study,” World Journal of Surgical Oncology, vol. 12, no. 1, article no. 260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  205. Y.-F. Zhang, W.-W. Shi, H.-F. Gao, L. Zhou, A.-J. Hou, and Y.-H. Zhou, “Folate intake and the risk of breast cancer: A dose-response meta-analysis of prospective studies,” PLoS ONE, vol. 9, no. 6, Article ID e100044, 2014. View at Publisher · View at Google Scholar · View at Scopus
  206. S. C. Larsson, L. Bergkvist, and A. Wolk, “Folate intake and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 12, pp. 3444–3449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  207. L. Yu, Y. Tan, and L. Zhu, “Dietary vitamin B2 intake and breast cancer risk: a systematic review and meta-analysis,” Archives of Gynecology and Obstetrics, vol. 295, no. 3, pp. 721–729, 2017. View at Publisher · View at Google Scholar
  208. C.-X. Zhang, S. C. Ho, Y.-M. Chen, F.-Y. Lin, J.-H. Fu, and S.-Z. Cheng, “Dietary folate, vitamin B 6, vitamin B 12 and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status,” British Journal of Nutrition, vol. 106, no. 6, pp. 936–943, 2011. View at Publisher · View at Google Scholar · View at Scopus
  209. Y.-C. Chou, C.-H. Chu, M.-H. Wu et al., “Dietary intake of vitamin B6 and risk of breast cancer in Taiwanese women,” Journal of Epidemiology, vol. 21, no. 5, pp. 329–336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  210. U. Ericson, E. Sonestedt, B. Gullberg, H. Olsson, and E. Wirfält, “High folate intake is associated with lower breast cancer incidence in postmenopausal women in the malmö diet and cancer cohort,” The American Journal of Clinical Nutrition, vol. 86, no. 2, pp. 434–443, 2007. View at Google Scholar
  211. M. Lajous, I. Romieu, S. Sabia, M.-C. Boutron-Ruault, and F. Clavel-Chapelon, “Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women,” Cancer Causes and Control, vol. 17, no. 9, pp. 1209–1213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  212. M. J. Shrubsole, F. Jin, Q. Dai et al., “Dietary folate intake and breast cancer risk: results from the shanghai breast cancer study,” Cancer Research, vol. 61, no. 19, pp. 7136–7141, 2001. View at Google Scholar
  213. D. Yang, R. N. Baumgartner, M. L. Slattery et al., “Dietary Intake of Folate, B-Vitamins and Methionine and Breast Cancer Risk among Hispanic and Non-Hispanic White Women,” PLoS ONE, vol. 8, no. 2, Article ID e54495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  214. M. J. Shrubsole, X. O. Shu, H.-L. Li et al., “Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women,” American Journal of Epidemiology, vol. 173, no. 10, pp. 1171–1182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  215. S. C. Larsson, E. Giovannucci, and A. Wolk, “Folate and risk of breast cancer: A meta-analysis,” Journal of the National Cancer Institute, vol. 99, no. 1, pp. 64–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  216. S. M. Zhang, W. C. Willett, J. Selhub et al., “Plasma folate, vitamin B6, vitamin B12, homocysteine and risk of breast cancer,” Journal of the National Cancer Institute, vol. 95, pp. 373–380, 2003. View at Google Scholar
  217. W. Wu, S. Kang, and D. Zhang, “Association of vitamin B 6, vitamin B 12 and methionine with risk of breast cancer: A dose-response meta-analysis,” British Journal of Cancer, vol. 109, no. 7, pp. 1926–1944, 2013. View at Publisher · View at Google Scholar · View at Scopus
  218. C. Agnoli, S. Grioni, V. Krogh et al., “Plasma riboflavin and vitamin B-6, but not homocysteine, folate, or vitamin B-12, are inversely associated with breast cancer risk in the european prospective investigation into cancer and nutrition-varese cohort,” Journal of Nutrition, vol. 146, no. 6, pp. 1227–1234, 2016. View at Publisher · View at Google Scholar · View at Scopus
  219. J. M. He, C. Liping, and L. Dequan, “Association between dietary intake of folate, Vitamin B-6, B-12 & MTHFR, MTR Genotype and breast cancer risk,” Genetics and Molecular Research, vol. 13, no. 84, pp. 8925–8931, 2014. View at Google Scholar
  220. E. Ma, M. Iwasaki, M. Kobayashi et al., “Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: A case-control study in Japan,” Nutrition and Cancer, vol. 61, no. 4, pp. 447–456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  221. Q. Jiang-hua, J. De-chuang, L. Zhen-duo, C. Shu-de, and L. Zhenzhen, “Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B12 intakes,” Tumor Biology, vol. 35, no. 12, pp. 11895–11901, 2014. View at Publisher · View at Google Scholar · View at Scopus
  222. Z. Weiwei, C. Liping, and L. Dequan, “Association between dietary intake of folate, vitamin B6, B12 & MTHFR, MTR Genotype and breast cancer risk,” Pakistan Journal of Medical Sciences, vol. 30, no. 1, pp. 106–110, 2014. View at Google Scholar
  223. Y. Liu, L.-S. Zhou, X.-M. Xu, L.-Q. Deng, and Q.-K. Xiao, “Association of dietary intake of folate, vitamin B6 and B12 and MTHFR genotype with breast cancer risk,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 9, pp. 5189–5192, 2013. View at Publisher · View at Google Scholar · View at Scopus
  224. E. Ma, M. Iwasaki, I. Junko et al., “Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: A case-control study in Brazilian women,” BMC Cancer, vol. 9, article no. 122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  225. S. Pirouzpanah, F.-A. Taleban, P. Mehdipour, and M. Atri, “Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients,” Journal of Molecular Medicine, vol. 93, no. 8, pp. 917–934, 2015. View at Publisher · View at Google Scholar · View at Scopus
  226. X. Xu, M. D. Gammon, J. G. Wetmur et al., “B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 8, pp. 2109–2116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  227. J. Wohlrab, N. Bangemann, A. Kleine-Tebbe et al., “Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer,” Breast Cancer: Targets and Therapy, vol. 6, pp. 115–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  228. S. Straka, J. L. Lester, R. M. Cole et al., “Incorporation of eicosapentaenioic and docosahexaenoic acids into breast adipose tissue of women at high risk of breast cancer: A randomized clinical trial of dietary fish and n-3 fatty acid capsules,” Molecular Nutrition and Food Research, vol. 59, no. 9, pp. 1780–1790, 2015. View at Publisher · View at Google Scholar · View at Scopus
  229. C. Pouchieu, V. Chajès, F. Laporte et al., “Prospective associations between plasma saturated, monounsaturated and polyunsaturated fatty acids and overall and breast cancer risk - modulation by antioxidants: A nested case-control study,” PLoS ONE, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  230. R. E. Patterson, S. W. Flatt, V. A. Newman et al., “Marine fatty acid intake is associated with breast cancer prognosis,” Journal of Nutrition, vol. 141, no. 2, pp. 201–206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  231. Y. Cao, L. Hou, and W. Wang, “Dietary total fat and fatty acids intake, serum fatty acids and risk of breast cancer: A meta-analysis of prospective cohort studies,” International Journal of Cancer, vol. 138, no. 8, pp. 1894–1904, 2016. View at Publisher · View at Google Scholar · View at Scopus
  232. P. M. Witt, J. H. Christensen, E. B. Schmidt et al., “Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: A case-cohort study from Denmark,” Cancer Causes and Control, vol. 20, no. 9, pp. 1715–1721, 2009. View at Publisher · View at Google Scholar · View at Scopus
  233. W. Zhihui, Y. Weihua, W. Zupei, and H. Jinlin, “Fish consumption and risk of breast cancer: meta-analysis of 27 observational studies,” Nutricion Hospitalaria, vol. 33, no. 3, p. 282, 2016. View at Google Scholar
  234. D. Engeset, E. Alsaker, E. Lund et al., “Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC),” International Journal of Cancer, vol. 119, no. 1, pp. 175–182, 2006. View at Google Scholar
  235. T. M. Brasky, J. W. Lampe, J. D. Potter, R. E. Patterson, and E. White, “Specialty supplements and breast cancer risk in the VITamins and Lifestyle (VITAL) cohort,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 7, pp. 1696–1708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  236. J. Kim, S.-Y. Lim, A. Shin et al., “Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: A case-control study,” BMC Cancer, vol. 9, article no. 216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  237. L. R. Orr, J. Bruce Redmon, M. S. Kurzer, and S. K. Raatz, “Effect of high omega-3 fatty acid diet on markers of breast cancer risk in postmenopausal women,” The FASEB Journal, vol. 23, supplement 558.2, no. 1, 2009. View at Google Scholar
  238. J. S. Zheng, X. J. Hu, Y. M. Zhao, J. Yang, and D. Li, “ntake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies,” British Medical Journal, vol. 346, Article ID f3706, 2013. View at Publisher · View at Google Scholar · View at Scopus
  239. B. Yang, X.-L. Ren, Y.-Q. Fu, J.-L. Gao, and D. Li, “Ratio of n-3/n-6 PUFAs and risk of breast cancer: A meta-analysis of 274135 adult females from 11 independent prospective studies,” BMC Cancer, vol. 14, no. 1, article no. 105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  240. H. J. Murff, X. Shu, H. Li et al., “Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort studyomega-3,” International Journal of Cancer, vol. 128, no. 6, pp. 1434–1441, 2011. View at Publisher · View at Google Scholar
  241. N. K. Khankari, P. T. Bradshaw, S. E. Steck et al., “Polyunsaturated fatty acid interactions and breast cancer incidence: A population-based case-control study on Long Island, New York,” Annals of Epidemiology, vol. 25, no. 12, pp. 929–935, 2015. View at Publisher · View at Google Scholar · View at Scopus
  242. L. D. Yee, J. L. Lester, R. M. Cole et al., “ω-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition,” The American Journal of Clinical Nutrition, vol. 91, no. 5, pp. 1185–1194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  243. C. J. Fabian, B. F. Kimler, T. A. Phillips et al., “Modulation of breast cancer risk biomarkers by high-dose omega-3 fatty acids: Phase II pilot study in postmenopausal women,” Cancer Prevention Research, vol. 8, no. 10, pp. 922–931, 2015. View at Publisher · View at Google Scholar · View at Scopus
  244. N. Sandhu, S. E. Schetter, J. Liao et al., “Influence of obesity on breast density reduction by omega-3 fatty acids: Evidence from a randomized clinical trial,” Cancer Prevention Research, vol. 9, no. 4, pp. 275–282, 2016. View at Publisher · View at Google Scholar · View at Scopus
  245. C. Signori, C. Dubrock, J. P. Richie et al., “Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: Interim feasibility and biomarkers analysis from a clinical trial,” European Journal of Clinical Nutrition, vol. 66, no. 8, pp. 878–884, 2012. View at Publisher · View at Google Scholar · View at Scopus
  246. C. Signori, J. P. Richie, B. Prokopczyk et al., “Effect of omega-3 fatty acids alone and in combination with raloxifene on biomarkers of breast cancer risk in postmenopausal healthy women at high risk,” Journal of Clinical Oncology, vol. 29, e11036, no. 15, 2011. View at Publisher · View at Google Scholar
  247. P. Bougnoux, N. Hajjaji, M. N. Ferrasson, B. Giraudeau, C. Couet, and O. Le Floch, “Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial,” British Journal of Cancer, vol. 101, no. 12, pp. 1978–1985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  248. H. L. Hutchins-Wiese, K. Picho, B. A. Watkins et al., “High-Dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: A pilot study,” Nutrition and Cancer, vol. 66, no. 1, pp. 68–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  249. D. García Giménez, E. García Prado, T. Sáenz Rodríguez, A. Fernández Arche, and R. De La Puerta, “Cytotoxic effect of the pentacyclic oxindole alkaloid mitraphylline isolated from uncaria tomentosa bark on human ewing's sarcoma and breast cancer cell lines,” Planta Medica, vol. 76, no. 2, pp. 133–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  250. Y. Sheng, L. Li, K. Holmgren, and R. W. Pero, “DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study,” Phytomedicine, vol. 8, no. 4, pp. 275–282, 2001. View at Publisher · View at Google Scholar · View at Scopus
  251. Y. Sheng, R. W. Pero, and H. Wagner, “Treatment of chemotherapy-induced leukopenia in a rat model with aqueous extract from Uncaria tomentosa,” Phytomedicine, vol. 7, no. 2, pp. 137–143, 2000. View at Publisher · View at Google Scholar · View at Scopus
  252. S. Eberlin, L. M. B. dos Santos, and M. L. S. Queiroz, “Uncaria tomentosa extract increases the number of myeloid progenitor cells in the bone marrow of mice infected with Listeria monocytogenes,” International Immunopharmacology, vol. 5, no. 7-8, pp. 1235–1246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  253. I. Farias, M. do Carmo Araújo, and E. S. Zimmermann, “Uncaria tomentosa stimulates the proliferation of myeloid progenitor cells,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 856–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  254. Y. Sheng, C. Bryngelsson, and R. W. Pero, “Enhanced DNA repair, immune function and reduced toxicity of C-MED-100(TM), a novel aqueous extract from Uncaria tomentosa,” Journal of Ethnopharmacology, vol. 69, no. 2, pp. 115–126, 2000. View at Publisher · View at Google Scholar · View at Scopus
  255. L. Allen-Hall, P. Cano, J. T. Arnason, R. Rojas, O. Lock, and R. M. Lafrenie, “Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1β and TNF-α,” Journal of Ethnopharmacology, vol. 109, no. 2, pp. 312–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  256. F. Budán, I. Szabõ, T. Varjas et al., “Mixtures of Uncaria and Tabebuia extracts are potentially chemopreventive in CBA/Ca mice: A long-term experiment,” Phytotherapy Research, vol. 25, no. 4, pp. 493–500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  257. S. Lamm, Y. Sheng, and R. W. Pero, “Persistent response to pneumococcal vaccine in individuals supplemented with a novel water soluble extract of Uncaria tomentosa, C-Med-100®,” Phytomedicine, vol. 8, no. 4, pp. 267–274, 2001. View at Publisher · View at Google Scholar · View at Scopus
  258. S. Alam, D. Katiyar, R. Goel, A. Vats, and A. Mittal, “Role of herbals in cancer management,” The Journal of Phytopharmacology, vol. 2, pp. 46–51, 2013. View at Google Scholar
  259. J. A. Milner, “Garlic: its anticarcinogenic and antitumorigenic properties,” Nutrition Reviews, vol. 54, no. 11, pp. S82–S86, 1996. View at Google Scholar · View at Scopus
  260. Y. Liu, P. Zhu, Y. Wang et al., “Antimetastatic therapies of the polysulfide diallyl trisulfide against triple-negative breast cancer (TNBC) via suppressing MMP2/9 by blocking NF-κB and ERK/MAPK signaling pathways,” PLoS ONE, vol. 10, no. 4, Article ID e0123781, 2015. View at Publisher · View at Google Scholar · View at Scopus
  261. K. Chandra-Kuntal, J. Lee, and S. V. Singh, “Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic,” Breast Cancer Research and Treatment, vol. 138, no. 1, pp. 69–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  262. A. Malki, M. El-Saadani, and A. S. Sultan, “Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells,” Cancer biology & therapy, vol. 8, no. 22, pp. 2175–2185, 2009. View at Google Scholar · View at Scopus
  263. Y. M. Nkrumah-Elie, J. S. Reuben, A. Hudson et al., “Diallyl trisulfide as an inhibitor of benzo(a)pyrene-induced precancerous carcinogenesis in MCF-10A cells,” Food and Chemical Toxicology, vol. 50, no. 7, pp. 2524–2530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  264. A. Tsubura, Y.-C. Lai, M. Kuwata, N. Uehara, and K. Yoshizawa, “Anticancer effects of garlic and garlic-derived compounds for breast cancer control,” Anti-Cancer Agents in Medicinal Chemistry, vol. 11, no. 3, pp. 249–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  265. H.-K. Na, E.-H. Kim, M.-A. Choi, J.-M. Park, D.-H. Kim, and Y.-J. Surh, “Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1,” Biochemical Pharmacology, vol. 84, no. 10, pp. 1241–1250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  266. H. Nakagawa, K. Tsuta, K. Kiuchi et al., “Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines,” Carcinogenesis, vol. 22, no. 6, pp. 891–897, 2001. View at Publisher · View at Google Scholar · View at Scopus
  267. S. Shishodia and B. B. Aggarwal, “Nuclear factor-kappaB activation: a question of life or death,” Journal of Biochemistry and Molecular Biology, vol. 35, no. 1, pp. 28–40, 2002. View at Publisher · View at Google Scholar · View at Scopus
  268. V. A. Kiesel and S. D. Stan, “Diallyl trisulfide, a chemopreventive agent from Allium vegetables, inhibits alpha-secretases in breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 484, no. 4, pp. 833–838, 2017. View at Publisher · View at Google Scholar
  269. P. Mason, Dietary Supplements, 3rd edition, 2007, Pharmaceutical Press.
  270. L. U. Thompson, P. Robb, M. Serraino, and F. Cheung, “Mammalian Lignan Production From Various Foods,” Nutrition and Cancer, vol. 16, no. 1, pp. 43–52, 1991. View at Publisher · View at Google Scholar · View at Scopus
  271. H. B. Mabrok, R. Klopfleisch, K. Z. Ghanem, T. Clavel, M. Blaut, and G. Loh, “Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer,” Carcinogenesis, vol. 33, no. 1, pp. 203–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  272. J. K. Mason and L. U. Thompson, “Flaxseed and its lignan and oil components: Can they play a role in reducing the risk of and improving the treatment of breast cancer?” Applied Physiology, Nutrition and Metabolism, vol. 39, no. 6, pp. 663–678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  273. J. Lee and K. Cho, “Flaxseed sprouts induce apoptosis and inhibit growth in MCF-7 and MDA-MB-231 human breast cancer cells,” In Vitro Cellular and Developmental Biology - Animal, vol. 48, no. 4, pp. 244–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  274. C. Theil, V. Briese, D.-U. Richter, U. Jeschke, and K. Friese, “An ethanolic extract of Linum usitatissimum caused cell lethality and inhibition of cell vitality/—proliferation of MCF-7 and BT20 mamma carcinoma cells in vitro,” Archives of Gynecology and Obstetrics, vol. 288, no. 1, pp. 149–153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  275. A. K. A. Wiggins, S. Kharotia, J. K. Mason, and L. U. Thompson, “Linolenic Acid Reduces Growth of Both Triple Negative and Luminal Breast Cancer Cells in High and Low Estrogen Environments,” Nutrition and Cancer, vol. 67, no. 6, pp. 1001–1009, 2015. View at Publisher · View at Google Scholar · View at Scopus
  276. A. Sorice, E. Guerriero, M. G. Volpe et al., “Differential response of two human breast cancer cell lines to the phenolic extract from flaxseed oil,” Molecules, vol. 21, no. 3, article no. 319, 2016. View at Publisher · View at Google Scholar · View at Scopus
  277. J. K. Saggar, J. Chen, P. Corey, and L. U. Thompson, “The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways,” Nutrition and Cancer, vol. 62, no. 4, pp. 533–542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  278. J. S. Truan, J. M. Chen, and L. U. Thompson, “Flaxseed oil reduces the growth of human breast tumours (MCF-7) at high levels of circulating estrogen,” Molecular Nutrition & Food Research, vol. 54, no. 10, pp. 1414–1421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  279. M. B. Jungeström, L. U. Thompson, and C. Dabrosin, “Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo,” Clinical Cancer Research, vol. 13, no. 3, pp. 1061–1067, 2007. View at Publisher · View at Google Scholar · View at Scopus
  280. J. Chen, J. K. Saggar, P. Corey, and L. U. Thompson, “Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice,” British Journal of Nutrition, vol. 105, no. 3, pp. 339–347, 2011. View at Publisher · View at Google Scholar · View at Scopus
  281. J. Chen, J. K. Saggar, P. Corey, and L. U. Thompson, “Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice,” Journal of Nutrition, vol. 139, no. 11, pp. 2061–2066, 2009. View at Publisher · View at Google Scholar · View at Scopus
  282. L. Wang, J. Chen, and L. U. Thompson, “The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components,” International Journal of Cancer, vol. 116, no. 5, pp. 793–798, 2005. View at Publisher · View at Google Scholar · View at Scopus
  283. J. Chen, K. A. Power, J. Mann, A. Cheng, and L. U. Thompson, “Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen,” Experimental Biology and Medicine, vol. 232, no. 8, pp. 1071–1080, 2007. View at Publisher · View at Google Scholar · View at Scopus
  284. C. Dabrosin, J. Chen, L. Wang, and L. U. Thompson, “Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts,” Cancer Letters, vol. 185, no. 1, pp. 31–37, 2002. View at Publisher · View at Google Scholar · View at Scopus
  285. L. U. Thompson, J. M. Chen, T. Li, K. Strasser-Weippl, and P. E. Goss, “Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer,” Clinical Cancer Research, vol. 11, no. 10, pp. 3828–3835, 2005. View at Publisher · View at Google Scholar · View at Scopus
  286. K. Buck, A. Vrieling, A. K. Zaineddin et al., “Serum enterolactone and prognosis of postmenopausal breast cancer,” Journal of Clinical Oncology, vol. 29, no. 28, pp. 3730–3738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  287. E. Guerriero, A. Sorice, F. Capone et al., “Combining doxorubicin with a phenolic extract from flaxseed oil: evaluation of the effect on two breast cancer cell lines,” International Journal of Oncology, vol. 50, no. 2, pp. 468–476, 2017. View at Publisher · View at Google Scholar
  288. J. K. Mason, M.-H. Fu, J. Chen, Z. Yu, and L. U. Thompson, “Dietary flaxseed-trastuzumab interactive effects on the growth of HER2-overexpressing human breast tumors (BT-474),” Nutrition and Cancer, vol. 65, no. 3, pp. 451–459, 2013. View at Publisher · View at Google Scholar · View at Scopus
  289. J. Mason, “Interactive effects of flaxseed oil and trastuzumab on the groeth of breast tumours overexpressing HER2,” in Nutritional Sciences, p. 86, Toronto, Toronto, Ontario, Canada, 2010. View at Google Scholar
  290. J. Chen, J. K. Saggar, W. E. Ward, and L. U. Thompson, “Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen,” Journal of Toxicology and Environmental Health - Part A: Current Issues, vol. 74, no. 12, pp. 757–768, 2011. View at Publisher · View at Google Scholar · View at Scopus
  291. A. Krup, L. H. Prakash, and A. Harini, “Pharmacological activities of turmeric (Curcuma longa linn): a reviw,” Journal of Homeopathy & Ayurvedic Medicine, vol. 2, pp. 133–136, 2013. View at Google Scholar
  292. D. Liu and Z. Chen, “The effect of curcumin on breast cancer cells,” Journal of Breast Cancer, vol. 16, no. 2, pp. 133–137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  293. A. B. Kunnumakkara, P. Anand, and B. B. Aggarwal, “Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins,” Cancer Letters, vol. 269, no. 2, pp. 199–225, 2008. View at Publisher · View at Google Scholar
  294. N. Cine, P. Limtrakul, D. Sunnetci, B. Nagy, and H. Savli, “Effects of curcumin on global gene expression profiles in the highly invasive human breast carcinoma cell line MDA-MB 231: a gene network-based microarray analysis,” Experimental and Therapeutic Medicine, vol. 5, no. 1, pp. 23–27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  295. M. Jiang, O. Huang, X. Zhang et al., “Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9,” Molecules, vol. 18, no. 1, pp. 701–720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  296. Y. Zhan, Y. Chen, R. Liu, H. Zhang, and Y. Zhang, “Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling,” Archives of Pharmacal Research, vol. 37, no. 8, pp. 1086–1095, 2014. View at Publisher · View at Google Scholar · View at Scopus
  297. H. J. Kang, S. H. Lee, J. E. Price, and L. S. Kim, “Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model,” The Breast Journal, vol. 15, no. 3, pp. 223–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  298. E. T. Quispe-Soto and G. M. Calaf, “Effect of curcumin and paclitaxel on breast carcinogenesis,” International Journal of Oncology, vol. 49, no. 6, pp. 2569–2577, 2016. View at Publisher · View at Google Scholar · View at Scopus
  299. Z. F. Zhong, W. Tan, K. Tian, H. Yu, W. Qiang, and Y. Wang, “Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro,” Oncology Reports, vol. 37, no. 4, pp. 2016–2024, 2017. View at Publisher · View at Google Scholar
  300. L. C. Ferreira, A. S. Arbab, B. V. Jardim-Perassi et al., “Effect of curcumin on pro-angiogenic factors in the xenograft model of breast cancer,” Anti-Cancer Agents in Medicinal Chemistry, vol. 15, no. 10, pp. 1285–1296, 2015. View at Publisher · View at Google Scholar · View at Scopus
  301. T.-L. Chiu and C.-C. Su, “Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells,” International Journal of Molecular Medicine, vol. 23, no. 4, pp. 469–475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  302. H. Zong, F. Wang, Q.-X. Fan, and L.-X. Wang, “Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways,” Molecular Biology Reports, vol. 39, no. 4, pp. 4803–4808, 2012. View at Publisher · View at Google Scholar · View at Scopus
  303. S. Bimonte, A. Barbieri, G. Palma et al., “Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer,” BioMed Research International, vol. 2015, Article ID 878134, 2015. View at Publisher · View at Google Scholar · View at Scopus
  304. H.-W. Lai, S.-Y. Chien, S.-J. Kuo et al., “The potential utility of curcumin in the treatment of HER-2-overexpressed breast cancer: an in vitro and in vivo comparison study with herceptin,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 486568, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  305. H. Fan, Y. Liang, B. Jiang et al., “Curcumin inhibits intracellular fatty acid synthase and induces apoptosis in human breast cancer MDA-MB-231 cells,” Oncology Reports, vol. 35, no. 5, pp. 2651–2656, 2016. View at Publisher · View at Google Scholar · View at Scopus
  306. C. E. Carroll, M. R. Ellersieck, and S. M. Hyder, “Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells,” Menopause, vol. 15, no. 3, pp. 570–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  307. G. Chakraborty, S. Jain, S. Kale et al., “Curcumin suppresses breast tumour angiogenesis by abrogating osteopontin-induced VEGF expression,” Molecular Medicine Reports, vol. 1, no. 5, pp. 641–646, 2008. View at Google Scholar
  308. Y. H. Soung and J. Chung, “Curcumin inhibition of the functional interaction between integrin alpha6beta4 and the epidermal growth factor receptor,” Molecular Cancer Therapeutics, vol. 10, no. 5, pp. 883–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  309. M. M. Yallapu, M. Jaggi, and S. C. Chauhan, “Curcumin nanoformulations: a future nanomedicine for cancer,” Drug Discovery Today, vol. 17, no. 1-2, pp. 71–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  310. M. Z. Ahmad, S. A. Alkahtani, S. Akhter et al., “Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: Current state-of-the-art,” Journal of Drug Targeting, vol. 24, no. 4, pp. 273–293, 2016. View at Publisher · View at Google Scholar · View at Scopus
  311. M. M. Yallapu, S. F. Othman, E. T. Curtis et al., “Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications,” International Journal of Nanomedicine, vol. 7, pp. 1761–1779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  312. P. Verderio, P. Bonetti, M. Colombo, L. Pandolfi, and D. Prosperi, “Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells,” Biomacromolecules, vol. 14, no. 3, pp. 672–682, 2013. View at Publisher · View at Google Scholar · View at Scopus
  313. Y. Cai, Z. Sun, X. Fang et al., “Synthesis, characterization and anti-cancer activity of Pluronic F68–curcumin conjugate micelles,” Drug Delivery, vol. 23, no. 7, pp. 2587–2595, 2016. View at Publisher · View at Google Scholar · View at Scopus
  314. S. Somasundaram, Edmund N. A., Moore D. T., Small G. W., Shi Y. Y., and Orlowski R. Z., “Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer,” Cancer Research, vol. 62, no. 13, pp. 3868–3875, 2002. View at Google Scholar
  315. N. T. Zaveri, “Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications,” Life Sciences, vol. 78, no. 18, pp. 2073–2080, 2006. View at Publisher · View at Google Scholar · View at Scopus
  316. R. L. Thangapazham, N. Passi, and R. K. Maheshwari, “Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells,” Cancer Biology and Therapy, vol. 6, no. 12, pp. 1938–1943, 2007. View at Publisher · View at Google Scholar
  317. R. L. Thangapazham, A. K. Singh, A. Sharma, J. Warren, J. P. Gaddipati, and R. K. Maheshwari, “Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo,” Cancer Letters, vol. 245, no. 1-2, pp. 232–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  318. Z. Wang, N. Wang, S. Han et al., “Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway,” PLoS ONE, vol. 8, no. 7, Article ID e68566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  319. A. H. Wu and L. M. Butler, “Green tea and breast cancer,” Molecular Nutrition and Food Research, vol. 55, no. 6, pp. 921–930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  320. E. Lecumberri, Y. M. Dupertuis, R. Miralbell, and C. Pichard, “Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy,” Clinical Nutrition, vol. 32, no. 6, pp. 894–903, 2013. View at Publisher · View at Google Scholar · View at Scopus
  321. F. Farabegoli, A. Papi, G. Bartolini, R. Ostan, and M. Orlandi, “(-)-epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line,” Phytomedicine, vol. 17, no. 5, pp. 356–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  322. T. Luo, J. Wang, Y. Yin et al., “(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma,” Breast Cancer Research, vol. 12, no. 1, article R8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  323. Y. Zhou, J. Tang, Y. Du, J. Ding, and J.-Y. Liu, “The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells,” Tumor Biology, vol. 37, no. 7, pp. 8555–8566, 2016. View at Publisher · View at Google Scholar · View at Scopus
  324. S.-H. Tu, C.-Y. Ku, C.-T. Ho et al., “Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells,” Molecular Nutrition & Food Research, vol. 55, no. 3, pp. 455–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  325. Y. Li, Y.-Y. Yuan, S. M. Meeran, and T. O. Tollefsbol, “Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells,” Molecular Cancer, vol. 9, article no. 274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  326. C. I. Coleman, J. H. Hebert, and P. Reddy, “The effects of Panax ginseng on quality of life,” Journal of Clinical Pharmacy and Therapeutics, vol. 28, no. 1, pp. 5–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  327. E. Ernst, “Prescribing herbal medications appropriately,” The Journal of Family Practice, vol. 53, no. 12, pp. 985–988, 2004. View at Google Scholar
  328. J.-M. Lü, Q. Yao, and C. Chen, “Ginseng compounds: an update on their molecular mechanisms and medical applications,” Current Vascular Pharmacology, vol. 7, no. 3, pp. 293–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  329. M. Blumenthal, “Herb sales down 15 percent in mainstream market,” HerbalGram, vol. 51, p. 69, 2001. View at Google Scholar
  330. D. L. Barton, H. Liu, S. R. Dakhil et al., “Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2,” Journal of the National Cancer Institute, vol. 105, no. 16, pp. 1230–1238, 2013. View at Google Scholar
  331. J.-N. Lai, C.-T. Wu, and J.-D. Wang, “Prescription pattern of Chinese herbal products for breast cancer in Taiwan: a population-based study,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 891893, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  332. J.-H. Kang, K.-H. Song, J.-K. Woo et al., “Ginsenoside Rp1 from Panax ginseng exhibits anti-cancer activity by down-regulation of the IGF-1R/Akt pathway in breast cancer cells,” Plant Foods for Human Nutrition, vol. 66, no. 3, pp. 298–305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  333. J. H. Kwak, J. Y. Park, D. Lee et al., “Inhibitory effects of ginseng sapogenins on the proliferation of triple negative breast cancer MDA-MB-231 cells,” Bioorganic and Medicinal Chemistry Letters, vol. 24, no. 23, pp. 5409–5412, 2014. View at Publisher · View at Google Scholar · View at Scopus
  334. A. S. Wong, C. M. Che, and K. W. Leung, “Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview,” Natural Product Reports, vol. 32, no. 2, pp. 256–272, 2015. View at Publisher · View at Google Scholar
  335. B. Kim, D. Kim, J. Park, Y. Surh, and H. Na, “Ginsenoside Rg3 inhibits constitutive activation of NF-kappaB signaling in human breast cancer (MDA-MB-231) cells: ERK and Akt as potential upstream targets,” Journal of Cancer Prevention, vol. 19, no. 1, pp. 23–30, 2014. View at Publisher · View at Google Scholar
  336. B. M. Kim, D. Kim, J. Park, H. Na, and Y. Surh, “Ginsenoside Rg3 Induces apoptosis of human breast cancer (MDA-MB-231) cells,” Journal of Cancer Prevention, vol. 18, no. 2, pp. 177–185, 2013. View at Publisher · View at Google Scholar
  337. M. Miao, Q. Liu, and Y. R. Liu, “Chemo-sensitivity enhancing effects of Shengai injection on various chemotherapeutic drugs,” Chinese Traditional and Herbal Drugs, vol. 44, pp. 875-876, 2013. View at Google Scholar
  338. N.-H. Lee and C.-G. Son, “Systematic Review of Randomized Controlled Trials Evaluating the Efficacy and Safety of Ginseng,” JAMS Journal of Acupuncture and Meridian Studies, vol. 4, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  339. J. T. Coon and E. Ernst, “Panax ginseng: a systematic review of adverse effects and drug interactions,” Drug Safety, vol. 25, no. 5, pp. 323–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  340. R. Baber, M. Hickey, and M. Kwik, “Therapy for menopausal symptoms during and after treatment for breast cancer: Safety considerations,” Drug Safety, vol. 28, no. 12, pp. 1085–1100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  341. H. H. Henneicke-von Zepelin, “60 years of Cimicifuga racemosa medicinal products: Clinical research milestones, current study findings and current development,” Wiener Medizinische Wochenschrift, vol. 167, no. 7-8, pp. 147–159, 2017. View at Publisher · View at Google Scholar
  342. S. Rockwell, Y. Liu, and S. A. Higgins, “Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh,” Breast Cancer Research and Treatment, vol. 90, no. 3, pp. 233–239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  343. H.-Y. Sun, B.-B. Liu, J.-Y. Hu et al., “Novel cycloartane triterpenoid from Cimicifuga foetida (Sheng ma) induces mitochondrial apoptosis via inhibiting Raf/MEK/ERK pathway and Akt phosphorylation in human breast carcinoma MCF-7 cells,” Chinese Medicine (United Kingdom), vol. 11, no. 1, article no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  344. Y. Kong, F. Li, Y. Nian et al., “KHF16 is a leading structure from Cimicifuga foetida that suppresses breast cancer partially by inhibiting the NF-κb signaling pathway,” Theranostics, vol. 6, no. 6, pp. 875–886, 2016. View at Publisher · View at Google Scholar · View at Scopus
  345. G. G.-L. Yue, S. Xie, J. K.-M. Lee et al., “New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment,” Scientific Reports, vol. 6, Article ID 35263, 2016. View at Publisher · View at Google Scholar · View at Scopus
  346. L. S. Einbond, J. Mighty, S. Redenti, and H.-A. Wu, “Actein induces calcium release in human breast cancer cells,” Fitoterapia, vol. 91, pp. 28–38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  347. U. Weissenstein, M. Kunz, K. Urech, U. Regueiro, and S. Baumgartner, “Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, article no. 271, 2016. View at Publisher · View at Google Scholar · View at Scopus
  348. V. L. Davis, M. J. Jayo, A. Ho et al., “Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2,” Cancer Research, vol. 68, no. 20, pp. 8377–8383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  349. H. Maroof, Z. M. Hassan, A. M. Mobarez, and M. A. Mohamadabadi, “Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model,” Journal of Clinical Immunology, vol. 32, no. 6, pp. 1353–1359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  350. D. Seidlová-Wuttke, O. Hesse, H. Jarry et al., “Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: Comparison with estradiol-17β,” European Journal of Endocrinology, vol. 149, no. 4, pp. 351–362, 2003. View at Publisher · View at Google Scholar · View at Scopus
  351. W. Wuttke, C. Gorkow, and D. Seidlová-Wuttke, “Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study,” Menopause, vol. 13, no. 2, pp. 185–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  352. W. Wuttke, D. Seidlová-Wuttke, and C. Gorkow, “The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: Effects on menopause symptoms and bone markers,” Maturitas, vol. 44, pp. S67–S77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  353. R. D. Koos, “Minireview: putting physiology back into estrogens' mechanism of action,” Endocrinology, vol. 152, no. 12, pp. 4481–4488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  354. B. A. Pockaj, J. G. Gallagher, C. L. Loprinzi et al., “Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG trial N01CC,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2836–2841, 2006. View at Publisher · View at Google Scholar · View at Scopus
  355. B. A. Pockaj, C. L. Loprinzi, J. A. Sloan et al., “Pilot evaluation of black cohosh for the treatment of hot flashes in women,” Cancer Investigation, vol. 22, no. 4, pp. 515–521, 2004. View at Publisher · View at Google Scholar · View at Scopus
  356. T. Nißlein and J. Freudenstein, “Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma,” Planta Medica, vol. 73, no. 4, pp. 318–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  357. B. J. Gurley, S. F. Gardner, M. A. Hubbard et al., “In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes,” Clinical Pharmacology and Therapeutics, vol. 77, no. 5, pp. 415–426, 2005. View at Publisher · View at Google Scholar · View at Scopus
  358. B. J. Gurley, A. Swain, M. A. Hubbard et al., “Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea,” Molecular Nutrition and Food Research, vol. 52, no. 7, pp. 755–763, 2008. View at Publisher · View at Google Scholar · View at Scopus
  359. S. Belisle, J. Blake, R. Basson et al., “Canadian Consensus Conference on menopause, 2006 update,” Journal of Obstetrics and Gynaecology Canada, vol. 28, 1, no. 2, pp. S7–S94, 2006. View at Publisher · View at Google Scholar
  360. R. Walji, H. Boon, E. Guns, D. Oneschuk, and J. Younus, “Black cohosh (Cimicifuga racemosa [L.] Nutt.): Safety and efficacy for cancer patients,” Supportive Care in Cancer, vol. 15, no. 8, pp. 913–921, 2007. View at Publisher · View at Google Scholar · View at Scopus
  361. J. Freudenstein, C. Dasenbrock, and T. Nisslein, “Lack of promotion of estrogen-dependent mammary gland tumours in vivo by an isopropanolic Cimicifuga racemosa extract,” Cancer Research, vol. 62, no. 12, pp. 3448–3452, 2002. View at Google Scholar · View at Scopus
  362. R. Teschke, “Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review,” Menopause, vol. 17, no. 2, pp. 426–440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  363. A. Büssing, “Biological and pharmacological properties of Viscum album L,” in Mistletoe. The Genus Viscum, Harwood Academic Publishers, Amsterdam, The Netherlands, 2000. View at Google Scholar
  364. T. Hajto, K. Hostanska, J. Fischer, and R. Saller, “Immunomodulatory effects of Viscum album agglutinin-I on natural immunity,” Anti-Cancer Drugs, vol. 8, no. 1, pp. S43–S46, 1997. View at Publisher · View at Google Scholar · View at Scopus
  365. I. F. Pryme, S. Bardocz, A. Pusztai, and S. W. B. Ewen, “Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins,” Histology and Histopathology, vol. 21, no. 3, pp. 285–299, 2006. View at Google Scholar
  366. M. Harmsma, M. Ummelen, W. Dignef, K. J. Tusenius, and F. C. S. Ramaekers, “Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumour cells,” Arzneimittelforschung, vol. 56, no. 6A, pp. 474–482, 2006. View at Google Scholar
  367. F. C. S. Ramaekers, M. Harmsma, K. J. Tusenius, B. Schutte, M. Werner, and M. Ramos, “Mistletoe extracts (Viscum album L.) Iscador interact with the cell cycle machinery and target survival mechanisms in cancer cells,” Medicina, vol. 67, no. 2, pp. 79–84, 2007. View at Google Scholar · View at Scopus
  368. N. E. Gardin, “Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series,” Phytotherapy Research, vol. 23, no. 3, pp. 407–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  369. G. S. Son, W. S. Ryu, H. Y. Kim, S. U. Woo, K. H. Park, and J. W. Bae, “Immunologic response to mistletoe extract (Viscum album L.) after conventional treatment in patients with operable breast cancer,” Journal of Breast Cancer, vol. 13, no. 1, pp. 14–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  370. G. Kelter, J. M. Schierholz, I. U. Fischer, and H. H. Fiebig, “Cytotoxic activity and absence of tumour growth stimulation of standardized mistletoe extracts in human tumour models in vitro,” Anticancer Research, vol. 1A, pp. 223–233, 2007. View at Google Scholar
  371. U. Weissenstein, M. Kunz, K. Urech, and S. Baumgartner, “Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro,” BMC Complementary and Alternative Medicine, vol. 14, article no. 6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  372. C.-E. Hong, A.-K. Park, and S.-Y. Lyu, “Synergistic anticancer effects of lectin and doxorubicin in breast cancer cells,” Molecular and Cellular Biochemistry, vol. 394, no. 1-2, pp. 225–235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  373. J. Beuth, H. L. Ko, H. Schneider et al., “Intratumoural application of standardized mistletoe extracts down regulates tumour weight via decreased cell proliferation, increased apoptosis and necrosis in a murine model,” Anticancer Research, vol. 26, no. 6B, pp. 4451–4456, 2006. View at Google Scholar
  374. L. S. Guo, H. X. Li, C. Y. Li et al., “Synergistic antitumour activity of vitamin D3 combined with metformin in human breast carcinoma MDA-MB-231 cells involves m-TOR related signaling pathways,” Pharmazie, vol. 70, no. 2, pp. 117–122, 2015. View at Google Scholar
  375. M. Thill, K. Reichert, A. Woeste et al., “Combined treatment of breast cancer cell lines with vitamin D and COX-2 inhibitors,” Anticancer Research, vol. 35, no. 2, pp. 1189–1195, 2015. View at Google Scholar
  376. M. C. Kahya, M. Naziroǧlu, and B. Çiǧ, “Selenium reduces mobile phone (900 MHz)-induced oxidative stress, mitochondrial function, and apoptosis in breast cancer cells,” Biological Trace Element Research, vol. 160, no. 2, pp. 285–293, 2014. View at Publisher · View at Google Scholar · View at Scopus
  377. C. L. Rock, C. Doyle, W. Demark-Wahnefried et al., “Nutrition and physical activity guidelines for cancer survivors,” CA: A Cancer Journal for Clinicians, vol. 62, no. 4, pp. 243–274, 2012. View at Publisher · View at Google Scholar
  378. W. C. R. F. a. A. I. f. C. R. WCRF, Cancer Survivors, 2015, http://www.dietandcancerreport.org/cancer_prevention_recommendations/recommendation_cancer_survivors.php.
  379. H. Greenlee, M. L. Kwan, I. J. Ergas et al., “Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: A prospective cohort study,” BMC Cancer, vol. 14, no. 1, article no. 382, 2014. View at Publisher · View at Google Scholar · View at Scopus
  380. J. Saquib, B. A. Parker, L. Natarajan et al., “Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer,” Complementary Therapies in Medicine, vol. 20, no. 5, pp. 283–290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  381. S. Nechuta, W. Lu, Z. Chen et al., “Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study,” Cancer Epidemiology Biomarkers & Prevention, vol. 20, no. 2, pp. 262–271, 2011. View at Publisher · View at Google Scholar
  382. G. R. Zirpoli, P. M. Brennan, C.-C. Hong et al., “Supplement use during an intergroup clinical trial for breast cancer (S0221),” Breast Cancer Research and Treatment, vol. 137, no. 3, pp. 903–913, 2013. View at Publisher · View at Google Scholar · View at Scopus
  383. M. Harvie, “Nutritional supplements and cancer: potential benefits and proven harms,” American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting, pp. e478–e486, 2014. View at Publisher · View at Google Scholar · View at Scopus
  384. L. H. Kushi, C. Doyle, M. McCullough et al., “American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the Risk of Cancer with Healthy Food Choices and Physical Activity,” CA Cancer Journal for Clinicians, vol. 62, no. 1, pp. 30–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  385. Cancer Research UK, The Safety of Vitamins and Dietary Supplements, 2015, http://www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/complementary-alternative/about/harm/the-safety-of-vitamins-and-diet-supplements.
  386. B. D. Lawenda and J. B. Blumberg, “Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?” Journal of the National Cancer Institute, vol. 100, no. 11, pp. 773–783, 2008. View at Publisher · View at Google Scholar
  387. G. M. D'Andrea, “Use of antioxidants during chemotherapy and radiotherapy should be avoided,” A Cancer Journal for Clinicians, vol. 55, no. 5, pp. 319–321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  388. C. Walker, “Antioxidant supplements do not improve mortality and may cause harm,” American Family Physician, vol. 78, no. 9, pp. 1079-1080, 2008. View at Google Scholar · View at Scopus
  389. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, “Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases,” Cochrane Database of Systematic Reviews, vol. 14, no. 3, Article ID CD007176, 2012. View at Google Scholar · View at Scopus
  390. N. Samuels, E. Schiff, and E. Ben-Arye, “Non-herbal nutritional supplements for symptom relief in adjuvant breast cancer: Creating a doctor-patient dialogue,” BMJ Supportive and Palliative Care, vol. 4, no. 3, Article ID Article e1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  391. C. Dennehy and C. Tsourounis, “A review of select vitamins and minerals used by postmenopausal women,” Maturitas, vol. 66, no. 4, pp. 370–380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  392. E. Doldo, G. Costanza, S. Agostinelli et al., “Vitamin A, cancer treatment and prevention: The new role of cellular retinol binding proteins,” BioMed Research International, vol. 2015, Article ID 624627, 2015. View at Publisher · View at Google Scholar · View at Scopus
  393. J. Lin, N. R. Cook, C. Albert et al., “Vitamins C and E and beta carotene supplementation and cancer risk: A randomized controlled trial,” Journal of the National Cancer Institute, vol. 101, no. 1, pp. 14–23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  394. Q. Chen, M. G. Espey, M. C. Krishna et al., “Pharamacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissuse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 38, pp. 13604–13609, 2005. View at Publisher · View at Google Scholar · View at Scopus
  395. M. F. Ullah, H. Y. Khan, H. Zubair, U. Shamim, and S. M. Hadi, “The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer,” Cancer Chemotherapy and Pharmacology, vol. 67, no. 1, pp. 103–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  396. J. K. Willcox, S. L. Ash, and G. L. Catignani, “Antioxidants and prevention of chronic disease,” Critical Reviews in Food Science and Nutrition, vol. 44, no. 4, pp. 275–295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  397. J. Hübner and V. Hanf, “Commonly used methods of complementary medicine in the treatment of breast cancer,” Breast Care, vol. 8, no. 5, pp. 341–347, 2013. View at Publisher · View at Google Scholar · View at Scopus
  398. A. J. McEligot, J. Largent, A. Ziogas, D. Peel, and H. Anton-Culver, “Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer,” Nutrition and Cancer, vol. 55, no. 2, pp. 132–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  399. C. Jacobs, B. Hutton, T. Ng, R. Shorr, and M. Clemons, “Is there a role for oral or intravenous ascorbate (Vitamin C) in treating patients with cancer? A systematic review,” Oncologist, vol. 20, no. 2, pp. 210–223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  400. T. Subramani, S. K. Yeap, W. Y. Ho et al., “Vitamin C suppresses cell death in MCF-7 human breast cancer cells induced by tamoxifen,” Journal of Cellular and Molecular Medicine, vol. 18, no. 2, pp. 305–313, 2014. View at Publisher · View at Google Scholar · View at Scopus
  401. G. Perrone, T. Hideshima, H. Ikeda et al., “Ascorbic acid inhibits antitumor activity of bortezomib in vivo,” Leukemia, vol. 23, no. 9, pp. 1679–1686, 2009. View at Publisher · View at Google Scholar · View at Scopus
  402. S. J. Padayatty, H. Sun, Y. Wang et al., “Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use,” Annals of Internal Medicine, vol. 140, no. 7, pp. 533–I61, 2004. View at Publisher · View at Google Scholar · View at Scopus
  403. H. Greenlee, D. L. Hershman, and J. S. Jacobson, “Use of antioxidant supplements during breast cancer treatment: A comprehensive review,” Breast Cancer Research and Treatment, vol. 115, no. 3, pp. 437–452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  404. L. J. Hoffer, M. Levine, S. Assouline et al., “Phase I clinical trial of i.v. ascorbic acid in advanced malignancy,” Annals of Oncology, vol. 19, no. 11, pp. 1969–1974, 2008. View at Google Scholar
  405. S. Swami, A. V. Krishnan, J. Y. Wang et al., “Dietary vitamin D 3and 1,25-dihydroxyvitamin D 3 (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer,” Endocrinology, vol. 153, no. 6, pp. 2576–2587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  406. J. Cha, M. W. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki, and M. Rath, “Ascorbate supplementation inhibits growth and metastasisof B16FO melanoma and 4T1 breast cancer cellsin vitamin C-deficient mice,” International Journal of Oncology, vol. 42, no. 1, pp. 55–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  407. T. E. Ichim, B. Minev, T. Braciak et al., “Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?” Journal of Translational Medicine, vol. 9, article no. 25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  408. G. Wang, T. Yin, and Y. Wang, “In vitro and in vivo assessment of high-dose vitamin C against murine tumors,” Experimental and Therapeutic Medicine, vol. 12, no. 5, pp. 3058–3062, 2016. View at Publisher · View at Google Scholar · View at Scopus
  409. E. Lonn, J. Bosch, S. Yusuf et al., “Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial,” The Journal of the American Medical Association, vol. 293, no. 11, pp. 1338–1347, 2005. View at Publisher · View at Google Scholar
  410. K.-W. Tam, C.-T. Ho, W.-J. Lee et al., “Alteration of α-tocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development,” Food Chemistry, vol. 138, no. 2-3, pp. 1015–1021, 2013. View at Publisher · View at Google Scholar · View at Scopus
  411. J.-H. Lee, B. Kim, W. J. Jin et al., “Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms,” Biochemical Pharmacology, vol. 91, no. 1, pp. 51–60, 2014. View at Publisher · View at Google Scholar · View at Scopus
  412. J. Walston, Q. Xue, R. D. Semba et al., “Serum antioxidants, inflammation, and total mortality in older women,” American Journal of Epidemiology, vol. 163, no. 1, pp. 18–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  413. J. Bleys, A. Navas-Acien, M. Laclaustra et al., “Serum selenium and peripheral arterial disease: Results from the national health and nutrition examination survey, 2003-2004,” American Journal of Epidemiology, vol. 169, no. 8, pp. 996–1003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  414. J. Beuth, “Evidence-based complementary oncology: innovative approaches to optimise standar therapy strategies,” Anticancer Research, vol. 30, no. 5, pp. 1767–1772, 2010. View at Google Scholar · View at Scopus
  415. G. Dennert, M. Zwahlen, M. Brinkman, M. Vinceti, M. P. A. Zeegers, and M. Horneber, “Selenium for preventing cancer,” Cochrane Database of Systematic Reviews, vol. 5, Article ID CD005195, 2011. View at Google Scholar · View at Scopus
  416. J. Beuth, “Evidence-based complementary medicine in breast cancer therapy,” Breast Care, vol. 4, no. 1, pp. 8–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  417. E.-H. Lee, S.-K. Myung, Y.-J. Jeon et al., “Effects of selenium supplements on cancer prevention: Meta-analysis of randomized controlled trials,” Nutrition and Cancer, vol. 63, no. 8, pp. 1185–1195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  418. X. Cai, C. Wang, W. Yu et al., “Selenium Exposure and Cancer Risk: An Updated Meta-analysis and Meta-regression,” Scientific Reports, vol. 6, Article ID 19213, 2016. View at Publisher · View at Google Scholar · View at Scopus
  419. U. Gröber, “Antioxidants and other micronutrients in complementary oncology,” Breast Care, vol. 4, no. 1, pp. 13–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  420. M. L. Adeoti, A. S. Oguntola, E. O. Akanni, O. S. Agodirin, and G. M. Oyeyemi, “Trace elements; Copper, zinc and selenium, in breast cancer afflicted female patients in LAUTECH Osogbo, Nigeria,” Indian Journal of Cancer, vol. 52, no. 1, pp. 106–109, 2015. View at Publisher · View at Google Scholar · View at Scopus
  421. R. Muecke, L. Schomburg, and M. Glatzel, “Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology,” International Journal of Radiation Oncology, Biology, Physics, vol. 70, pp. 825–835, 2010. View at Google Scholar
  422. M. Chung, E. M. Balk, M. Brendel, and etal., “Vitamin D and calcium: a systematic review of health outcomes,” Evidence Report/Technology Assessment, vol. 183, pp. 1–420, 2009. View at Google Scholar
  423. P. M. Brannon, E. A. Yetley, R. L. Bailey, and M. F. Picciano, “Overview of conference “Vitamin D and health in the 21st century: an update”,” The American Journal of Clinical Nutrition, vol. 88, pp. 483S–490S, 2008. View at Google Scholar
  424. G. Picotto, A. C. Liaudat, L. Bohl, and N. Tolosa de Talamoni, “Molecular aspects of vitamin d anticancer activity,” Cancer Investigation, vol. 30, no. 8, pp. 604–614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  425. S. Imtiaz and N. Siddiqui, “Vitamin-D status at breast cancer diagnosis: correlation with social and environmental factors and dietary intake,” Journal of Ayub Medical College, Abbottabad, vol. 26, no. 2, pp. 186–190, 2014. View at Google Scholar
  426. Z. Hong, C. Tian, and X. Zhang, “Dietary calcium intake, vitamin D levels, and breast cancer risk: A dose-response analysis of observational studies,” Breast Cancer Research and Treatment, vol. 136, no. 1, pp. 309–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  427. A. Hjartåker, M. Thoresen, D. Engeset, and E. Lund, “Dairy consumption and calcium intake and risk of breast cancer in a prospective cohort: The Norwegian Women and Cancer study,” Cancer Causes and Control, vol. 21, no. 11, pp. 1875–1885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  428. L. N. Anderson, “Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among caucasian women in Ontario,” Cancer Epidemiology, Biomarkers & Prevention, vol. 20, no. 8, pp. 1708–1717, 2011. View at Google Scholar
  429. M. L. McCullough, R. M. Bostick, and T. L. Mayo, “Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer,” Annual Review of Nutrition, vol. 29, pp. 111–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  430. Y. N. Urata, E. C. D. Lyra, M. L. H. Katayama et al., “Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients,” Clinical Nutrition, vol. 33, no. 1, pp. 136–142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  431. S. Singh, J. Cuzick, D. Mesher, B. Richmond, and A. Howell, “Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: Results from the IBIS-II, chemoprevention study using anastrozole,” Breast Cancer Research and Treatment, vol. 132, no. 2, pp. 625–629, 2012. View at Publisher · View at Google Scholar · View at Scopus
  432. A. C. Shapiro, S. A. Adlis, K. Robien et al., “Erratum: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS),” Breast Cancer Research and Treatment, vol. 157, no. 2, p. 403, 2016. View at Publisher · View at Google Scholar
  433. M. Chung, J. Lee, T. Terasawa, J. Lau, and T. A. Trikalinos, “Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force,” Annals of Internal Medicine, vol. 155, no. 12, pp. 827–838, 2011. View at Publisher · View at Google Scholar · View at Scopus
  434. S. Bourke, M. J. Bolland, A. Grey et al., “The impact of dietary calcium intake and vitamin D status on the effects of zoledronate,” Osteoporosis International, vol. 24, no. 1, pp. 349–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  435. Y. Rhee, K. Song, S. Park, H. S. Park, S.-K. Lim, and B. W. Park, “Efficacy of a combined alendronate and calcitriol agent (Maxmarvil®) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: A double-blind, randomized, placebo-controlled study,” Endocrine Journal, vol. 60, no. 2, pp. 167–172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  436. S. D. Manshadi, L. Ishiguro, K.-J. Sohn et al., “Folic acid supplementation promotes mammary tumor progression in a rat model,” PLoS ONE, vol. 9, no. 1, Article ID e84635, 2014. View at Publisher · View at Google Scholar · View at Scopus
  437. M. Lajous, J. de Batlle, C. Ricci et al., “Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort,” International Journal of Cancer, vol. 140, no. 6, pp. 1246–1259, 2017. View at Google Scholar
  438. C. M. Ulrich, “Folate and cancer prevention: a closer look at a complex picture,” The American Journal of Clinical Nutrition, vol. 86, pp. 271–273, 2007. View at Google Scholar
  439. P. Bougnoux, N. Hajjaji, K. Maheo, C. Couet, and S. Chevalier, “Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth,” Progress in Lipid Research, vol. 49, no. 1, pp. 76–86, 2010. View at Publisher · View at Google Scholar · View at Scopus